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ABSTRACT 
THE ROLE OF PROTEOME IN CELLULAR Zn2+ TRAFFICKING AND IN THE ABILITY OF 
FLUORESCENT ZINC SENSORS TO IMAGE INTRACELLULAR Zn2+ 
by 
Mohammad R. Karim 
The University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Professor David H. Petering 
 
Zinc is an essential biological trace metal used in as many as 3000 Zn-proteins, about 10% of the 
eukaryotic proteome, as either a structural constituent or a catalytic cofactor. These proteins 
include the zinc fingers, the most prevalent transcription factors that bind a wide range of gene 
promoters and thus regulate gene expression. A eukaryotic cell contains several hundred 
micromolar of Zn2+- almost all of it is bound to specific Zn-proteins. Recently, Zn2+ has been 
reported to serve as a regulatory signal and a neurotransmitter, suggesting that there also 
exists a dynamic Zn2+ pool in cells. These findings led to the synthesis of a wide range of 
fluorescent sensors to image intracellular mobile Zn2+. Despite extensive knowledge about 
thousands of Zn-proteins, the Zn2+ trafficking pathway from its entry into the cytosol by 
transporters to the formation of Zn-proteins is not well understood. This present work has 
studied the role of proteome in cellular Zn2+ trafficking using fluorescent zinc sensors, including 
FluoZin-3, Zinquin (ZQ), TSQ, Newport Green (NPG) and Zinpyr-1 (ZP1). The titration of 
proteome pre-treated with FluoZin-3, a relatively high affinity Zn2+ sensor with the stability 
constant of 15 nM, with Zn2+ has revealed that proteome contains a significant number of high 
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affinity, non-specific Zn2+ binding sites, with the stability constants on the order of 10-10 M. The 
discovery of these high affinity binding sites of proteome suggested that along with Zn-
metallothionein, proteome too can serve as a possible intermediate along the way to the 
formation of native Zn-proteins. Moreover, this finding raises the question how the majority of 
the fluorescent zinc sensors with the stability constants ranging from micromolar to nanomolar 
image intracellular labile Zn2+ by circumventing the proteome’s high zinc buffering capacity. 
Interestingly, the thiol binding reagents, N-ethylmaleimide (NEM) and DTNB abolished these 
high affinity sites, revealing the involvement of proteomic sulfhydryl groups in these Zn2+ 
binding sites. The loss of proteome’s zinc buffering capacity upon sulfhydryl modification can 
explain how the sensors bind the dynamic Zn2+ pool by surpassing the proteome’s high Zn2+ 
binding affinity. For example, Zinquin, a high affinity sensor with Kd of 2 nM, could bind the 
mobile Zn2+ only when the proteome was significantly modified by the reaction under 
investigation, such as the liberation of proteomic Zn2+ by nitric oxide, which reacts with the 
sulfhydryl groups and thus reduces proteome’s buffering capacity. In case of unperturbed 
proteome, these sensors either are unable to compete for mobile Zn2+ with proteome’s high 
affinity Zn2+ binding sites or generate ternary adduct, ProteomeZn-Sensor, with Zn2+ 
preferentially bound to proteome. Newport Green, for example, with its modest stability 
constant (Kd  10
-5 – 10-6 M) cannot efficiently compete with proteomic ligands to image mobile 
Zn2+. It could not bind intracellular Zn2+ shuttled into LLC-PK1 cells using the ionophore, 
pyrithione. Moreover, when proteomic Zn2+ was liberated by the reaction with sulfhydryl 
binding reagents, NEM and diethylamine NONOate (DEA-NO), in the presence of Newport 
Green, insignificant amount of Zn-NPG was detected. By contrast, the higher affinity Zn2+ sensor 
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(Kd  0.7 nM) than Newport Green, ZP1 formed ternary adduct ProteomeZn-ZP1 with the 
dynamic Zn2+, where Zn2+ is adventitiously bound to proteome’s high affinity zinc binding sites. 
Besides with the mobile Zn2+, ZP1 also seems to react with the static distribution of cellular Zn2+ 
in specific Zn-proteins and generates ZP1-Zn-Proteome ternary adduct. Therefore, the 
effectiveness of the sensors to bind the cellular dynamic Zn2+ is a variable of proteome’s Zn2+ 
binding characteristics. 
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1. INTRODUCTION 
Living organisms require a number of metal ions to serve both as structural constituents and 
catalytic cofactors in a wide range of proteins.1, 2 Among these biological metal ions, Zn2+ ranks 
the second in terms of abundance, immediately following iron.3  Because of having a fully 
occupied d-orbital (3d10), zinc does not participate in redox chemistry.  Nevertheless, it has 
been identified as an integral component in about 3,000 Zn-proteins, collectively known as Zn-
proteome, which make up about 10% of the eukaryotic proteome.4, 5 Examples of proteins in 
which Zn2+ serves as an important structural component include the most prevalent eukaryotic 
transcription factors – the Zn-finger proteins, which bind DNA and in turn, regulate gene 
expression.4, 6  Some of the well-known instances of enzymes containing Zn2+ as a catalytic 
cofactor are carbonic anhydrase, alcohol dehydrogenase, alkaline phosphatase, and so on. In 
these enzymes, Zn2+ can either act as a Lewis acid or help in holding the enzyme-substrate 
complex together, and thus assists in catalytic conversion of the substrate into product.7, 8  
Typically, the thiolate, carboxylate and/or imidazole ligands from cysteine, aspartate and 
histidine, respectively, bind Zn2+ occupying three coordination sites and thus leaving the fourth 
binding site for the substrate or other molecules, including water.9 However, other possible 
coordination numbers of Zn2+ in Zn-proteins have also been reported.4, 5, 10-12 
Eukaryotic cells contain several hundred micromolar of Zn2+.13, 14 Almost all of this is bound to 
proteins to make thousands of Zn-proteins.15 The concentration of steady-state cellular free or 
labile Zn2+ falls in the range of picomolar to nanomolar.3, 13, 14, 16 Despite the extensive research 
that has been carried out to understand the function of these thousands of Zn-proteins and the 
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role of Zn2+ in them, the mechanisms of Zn2+ trafficking that results in the generation of the 
native Zn-proteins are still not well understood. Copper, another cellular trace metal ion, is 
shuttled by different copper chaperon proteins to its target proteins.17-19 Copper trafficking 
pathways may suggest that zinc is also transported by various not yet discovered zinc chaperon 
proteins to find the target proteins. However, the important difference between copper and 
zinc proteins is that there is only a handful of copper proteins in the cell, as opposed to ca. 3000 
zinc proteins. To utilize the similar chaperone mediated pathway, Zn2+ will require perhaps 
hundreds to thousands of chaperone proteins, which seems to be unlikely.  
 
Figure 1.1 Hypothetical trafficking pathways of Zn2+ between and within cellular 
compartments. 
 
Figure 1.1 portrays a general model for Zn2+ trafficking pathways between the extracellular 
medium and the cytosol or among the cellular compartments.20 One possible trafficking 
pathway involves the binding of intracellular Zn2+ to apo-metallothionein, following the 
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transportation of Zn2+ - free or albumin bound (Zn-L) - into the cytosol from outside by 
membrane Zn2+ transporters of the ZIP family, to form Zn-Metallothionein, which then serves as 
a Zn2+ donor to apo Zn-proteins to generate specific Zn-proteins.20  An important cellular Zn-
protein, metallothionein (MT) can bind up to seven Zn2+ with high stability constants of 1011-12 
per Zn2+ in two Zn-thiolate clusters.21-24 The fully saturated metallothionein, Zn7-MT displays 
ligand substitution reactivity with apo-Zn-proteins such as carbonic anhydrase, which have 
large stability constants for Zn2+ (log K = 11-12).24-26 This reactivity suggests that Znn (1-7)-MT can 
serve as an intermediate along the way to form specific Zn-proteins (reactions 1 and 2).23, 24, 27, 
28 
n Zn2+ + apo-MT ⇌ Znn-MT                             (1) 
         Znn-MT + n apo-PN ⇌ n Zn-PN + apo-MT         (2) 
 
An alternative possible pathway is that Zn2+ transported into cytosol non-specifically binds to 
proteins containing potential Zn2+ binding sites (Zn-L2 or Zn-L3), and through ligand substitution 
is distributed randomly among different proteins of the proteome and small molecules such as 
glutathione.20 Finally, as Zn-Lk encounters apo-Zn-protein (apo-PN), Zn
2+ is transferred to 
generate native Zn-proteins (Zn-PN) (reaction 3). Proteome’s non-specifically zinc binding 
capacity has been reported in some recent studies.13, 29-33 
Zn2+ + L2 ⇌ Zn-L2;        Zn-L2 + L3 ⇌ Zn-L3 + L2; 
Zn-L3 + LK ⇌ Zn-LK + L3;       Zn-LK + PN ⇌ Zn-PN + LK        (3) 
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Moreover, the free Zn2+ pool resulting from the equilibrium between the randomly bound Zn2+ 
(Zn-LK) and the unbound Zn
2+ can bind to apo-Zn-protein (PN) to generate specific Zn-proteins 
(Zn-PN) (reaction 4).
20 This free Zn2+ pool may also participate in cellular Zn2+ signaling. 
Zn-LK ⇌ LK + Zn
2+;    Zn2+ + PN ⇌ Zn-PN           (4) 
Apart from the roles of important structural and catalytic components in Zn-proteins, Zn2+ also 
serves as an intracellular regulatory signal. The best studied example of Zn2+’s role as a 
regulatory signal in eukaryotic cells is the increased synthesis of metallothionein when the 
intracellular concentration of Zn2+ is elevated.34, 35 The elevated concentration of intracellular 
Zn2+ binds to apo-Zn-fingers of the metal response element (MRE) – binding transcription factor 
1 (MTF-1), and thus changes its conformation such that it can bind the MRE sequences of the 
promoter region of metallothionein and ZnT1 transporter genes (reaction 5).36-39 This 
association, in turn, stimulates the synthesis of metallothionein and ZnT1 transporter mRNAs, 
which then translate into apo-metallothionein and ZnT1 transporter proteins. Apo-
metallothionein binds the cell’s increased level of Zn2+ and ZnT1 transporters efflux Zn2+ out of 
the cell and thus, maintain the cellular zinc homeostasis.40 
MTF-1 inactive + n Zn
2+ ⇌ Znn (1-6)-MTF-1active 
         Znn-MTF-1 + MRE ⇌ Znn-MTF-1•MRE             (5) 
 
Moreover, various studies have reported the participation of Zn2+ in dyanamic cellular signaling 
processes such as synaptic chemical transmission and endocrine signaling.41, 42 Abundant in 
synaptic vesicles of glutamatergic neurons, Zn2+ is released into the synaptic cleft following 
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neuronal stimulation.43-45 However, the exact mechanism of how it serves as a signaling agent is 
yet to understand.  
The cellular roles of Zn2+ as a regulatory signal and a chemical messenger in neuronal synapses 
clearly suggest that it is not only bound to fixed binding sites in various Zn-proteins as structural 
and catalytic constituents. Rather, cells have a transient concentration of mobile or free Zn2+ 
generated by some stimulus, which in turn participates in cellular signaling.46 The generation of 
this dyanamic Zn2+ pool can be shown by the following equation: 
Zn-L + stimulus ⇌ Zn2+ + L              (6) 
L represents Zn2+ binding ligands, including Zn-protein and small molecules such as glutathione.  
Following the revelation of the transient mobile Zn2+ pool and its function in cellular signaling, 
the biochemical studies of Zn2+ metabolism has gained a new momentum. This required the 
discovery of some analytical tool to study the cellular functions of this dynamic Zn2+ pool. As 
yet, zinc fluorescent sensors have been considered the best analytical tool for this purpose. 
Over the past couple of decades, a number of fluorescent sensors with a wide variety of 
structures, stability constants ranging from micromolar to nanomolar, excitation wavelength 
(350 – 550 nm) and emission wavelength (450 – 600 nm) have been designed and synthesized 
to image the mobile Zn2+ pool of the cells.1, 2, 47-49 The structures of these fluorescent sensors 
contain a fluorophore reporter linked with the Zn2+ chelating ligand. Upon Zn2+ binding, sensors 
display an enhancement of fluorescence through photo-induced electron transfer (PET) 
quenching mechanism.1, 2 According to this mechanism, in the absence of Zn2+ ion, the electron 
rich receptor (chelating ligand) quenches the fluorescence of the fluorophore. As Zn2+ binds to 
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the receptor and thus prevents its interference in fluorescence emission, an enhancement of 
emission is followed.1, 2 
 
 
Figure 1.2 Examples of some commonly used fluorescent sensors to image cellular Zn2+. 
 
In typical experiments aimed at studying the dynamic cellular Zn2+ using fluorescent sensors, 
cells are incubated with the cell-permeable ester form of the sensor molecule (e.g. Zinquin, 
Newport Green, FluoZin-3 etc.), which following its entry into the cell gets cleaved by cellular 
esterases into its negatively charged acid form and thus becomes trapped inside the cell.50 
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However, some sensors (e.g. TSQ, Zinpyr-1) are charge neutral and can permeate the cell 
membrane, and thus their ester forms are not required for cellular use. Upon influx into the 
cell, the fluorescence enhancement and its reversal by the introduction of a cell permeable 
strong Zn2+ chelator, typically N, N, N’, N’-tetrakis (2-pyridylmethyl) ethane-1, 2-diamine (TPEN-
structure in Figure 1.2), are attributed to the imaging of free or labile Zn2+.46 The sensing of free 
Zn2+ pool generated by the equation (6) by the fluorescent sensor and its chelation by TPEN can 
be displayed by the following equations: 
Zn2+ + Sensor ⇌ Zn-Sensor                  (7) 
Zn-Sensor + TPEN ⇌ Zn-TPEN + Sensor            (8) 
 
The discovery of these fluorescent sensors has boosted the biochemical research of zinc 
metabolism, which, in turn, has revealed further evidence of the role of Zn2+ as a regulatory 
signal and secondary messenger. For example, an enhancement of a Zn2+ sensor fluorescence in 
brain injury models has led to the conclusion that labile or chelatable Zn2+ plays a crucial role in 
neurodegenerative diseases.51-53 In another study, pulmonary endothelial cells were exposed to 
nitric oxide or lipopolysaccharide in the presence of a zinc sensor that resulted in an increase of 
zinc sensor fluorescence signal, which suggested that Zn2+ participates in cellular signaling 
pathways that result in airway constriction.54-56 
Although the in vitro application of these fluorescent sensors to bind free Zn2+ is simple, their 
cellular use to image labile Zn2+ pool might be complicated due to a number of factors. Firstly, 
for quantitative measurement of free or competitively bound Zn2+ using these sensors, the 
stability constant of the sensor must be within the range of cellular free Zn2+ concentration or 
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similar to that of competing ligands for bound Zn2+. Moreover, in case of sensors with relatively 
high stability constants compared with cellular Zn2+ pools (ZnLk, Fig. 1.1) or with large 
intracellular concentration, the sensor might itself react with the bound Zn2+ pool of the cell 
and therefore, disturb the equilibrium between the Zn2+ bound to different ligands and free 
Zn2+ (reaction 5). Another possible unwanted reaction is that the sensor might directly chelate 
Zn2+ out of native Zn2+ binding sites (proteins or small molecules) (reaction 9). Both cases give 
rise to fluorescence enhancement, which may confuse the researchers with the fluorescence 
due to imaging of mobile Zn2+. 
Zn-Ligand + Sensor ⇌ Ligand + Zn-Sensor              (9) 
A significant number of studies have been done over the past two decades that used these 
fluorescent sensors to detect the mobile Zn2+ in cells.49, 57-63 However, the key drawback of most 
of these studies is that they relied mostly on fluorescent micrographs obtained following the 
incubation of cells with the sensor using a fluorescence microscope to draw their conclusions. 
Not much of the chemistry that occurs between the sensor and the cellular constituents has 
been investigated. The sole dependence on the fluorescence observation through a 
microscope, therefore, may often give misleading results. For example, 6-methoxy-8-p-
toluenesulfonamido-quinoline (TSQ) and its derivative Zinquin (ZQ) are two quinolone-based 
fluorophores commonly used by the researchers to image cellular free or labile Zn2+ pool.49, 57, 
61, 64 These fluorophores use their bidentate ligands comprised of quinoline and sulfonamide 
nitrogens to bind Zn2+ in a 2:1 stoichiometry (Figure 1.2).50, 65 Although structurally similar to 
TSQ, the presence of a methyl group at the 2 position enhances Zinquin’s affinity for Zn2+ 
 9 
 
(Figure 1.2), and therefore it can sense smaller intracellular Zn2+ concentration than TSQ.50 The 
fluorescence increase upon their treatment with cells has naively been attributed to their 
binding of Zn2+ to from fluorescent species Zn(TSQ)2 or Zn(ZQ)2. However, Meeusen et al. and 
Nowakowski et al. have shown that when used in cells, both TSQ and Zinquin actually image a 
subset of Zn-proteins, not free Zn2+ as various studies claimed, through the formation of the 
ternary adduct, TSQ-Zn-Protein or Zinquin-Zn-Protein.50, 65, 66 This subset of Zn-proteins imaged 
by TSQ or ZQ represents about 15-20% of the Zn-proteome. The generation of this ternary 
adduct species is quite evident from its different spectral properties. Zn(TSQ/ZQ)2 complex 
displays an emission maximum of 490 nm when excited at 370 nm, whereas (TSQ/ZQ)-Zn-
Protein ternary adduct gives a blue-shifted 470 nm emission. As Zinquin binds Zn2+ with higher 
affinity than TSQ, along with ZQ-Zn-Protein ternary adduct formation, it also may react with Zn-
proteome to generate Zn(ZQ)2 complex.
50  Like of Zn(TSQ/ZQ)2, the fluorescence of (TSQ/ZQ)-
Zn-Protein ternary adduct is also readily reversed by the reaction with the strong Zn2+ chelator 
TPEN. Meeusen et al. have also demonstrated that other than chelating Zn2+ out of the ternary 
adduct as Zn-TPEN, TPEN, itself  can also form ternary adduct TPEN-Zn-Protein by replacing the 
sensor.67 
2 Zn2+ + TSQ/ZQ ⇌ Zn(TSQ/ZQ)2         (emission, max  490 nm)      (10) 
TSQ/ZQ + Zn-Protein ⇌ (TSQ/ZQ)-Zn-Protein       (emission, max  470 nm)      (11) 
2 ZQ + Zn-Protein ⇌ Zn(ZQ)2 + apo-Protein         (12) 
(TSQ/ZQ)-Zn-Protein + TPEN ⇌ Zn-TPEN + TSQ/ZQ + apo-Protein        (13) 
(TSQ/ZQ)-Zn-Protein + TPEN ⇌ TPEN-Zn-Protein + TSQ/ZQ      (14) 
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This finding further deepens the question of what various sensors actually image at the cellular 
level. The present study has examined the chemical and biological properties of Newport 
Green, a fluorescent Zn2+ sensor with modest binding constant (Kd  10
-5 – 10-6 M) and its 
efficiency as a zinc sensor within the cellular framework. To compare with Newport Green 
results, a relatively higher affinity sensor, Zinpyr-1, with the binding constant of 0.7 nM has also 
been studied. Furthermore, having found that TSQ and Zinquin bind Zn-proteins to form ternary 
adducts (TSQ/Zinquin)-Zn-Protein, this study has investigated how TSQ, Zinquin and FluoZin-3 
interact with proteome incubated with diethylamine NONOate (DEA-NO). This nitric oxide (NO) 
donor spontaneously releases NO at physiological pH, which in turn reacts with proteomic 
sulfhydryl groups to induce the liberation of Zn2+ from native Zn-proteins. One of the key 
findings of these studies was that aside from the native Zn2+ binding sites of Zn-proteins, 
proteome possesses a good number of high affinity Zn2+ binding sites. Therefore, we next 
examined the proteomic components involved in these high affinity Zn2+ binding. Finally, the 
hypothesis that cells synthesize varied concentration of Zn-proteome at different phases of the 
cell cycle, which can explain the asymmetric distribution of fluorescence among neighboring 
LLC-PK1 cells observed by Meeusen et al. following the incubation of cells with TSQ, was 
investigated.   
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2. MATERIALS AND METHODS 
2.1 Chemicals and Reagents  
The zinc fluorescent sensors Newport Green, DCF diacetate (NPGE) and Newport Green 
dipotassium salt (NPGA) were purchased from Invitrogen, TSQ from AnaSpec, Inc., Zinquin – 
both acid and ethyl ester - from Enzo Life Sciences, FluoZin-3 from Molecular Probes, and 
Zinpyr-1 (ZP1) from Santa Cruz Biotechnology. All these zinc sensors were dissolved in DMSO 
and stored in the dark at -200 C in small aliquots. Diethylamine NONOate (DEA-NO) was 
obtained from Cayman Chemical. DEA-NO was dissolved in 0.01 M NaOH and stored in aliquots 
at -800 C until use. N-ethylmaleimide (NEM), nocodazole and thymidine were bought from 
Sigma.  All the other chemicals and reagents were purchased from either Fisher Scientific or 
Sigma-Aldrich at the highest grade available.  
The model zinc proteins alcohol dehydrogenase and carbonic anhydrase were obtained from 
Sigma in the form of lyophilized powder. The powders were dissolved in degassed 20 mM Tris 
adjusted to pH 7.4 and stored at -800 C. The antibiotics penicillin G and streptomycin sulfate for 
cell culture were purchased from Fisher Scientific and Sigma, respectively. Fetal calf serum (FCS) 
was also bought from Fisher Scientific and stored at -800 C until use.  
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2.2 Cell Culture  
2.2.1. Preparation of medium and solutions 
Both LLC-PK1 (pig kidney cells) cell line (adherent cell line) and CCRF-CEM human lymphocytic 
leukemia cells (suspension cell line) were purchased from ATCC and were grown in Medium 199 
with HEPES modification and RPMI 1640 medium, respectively. Medium powder from the 
bottle was dissolved in 1L MilliQ water. 2.2 g (for Medium 199) or 2.0 g (for RPMI 1640) sodium 
bicarbonate (NaHCO3) was added to the medium solution and the pH of the solution was 
adjusted to 7.2. The medium was then supplemented with 50 mg/L penicillin G and 50 mg/L 
streptomycin sulfate, and sterile filtered before use.  
Confluent LLC-PK1 cells were released from the culture flask by 10X trypsin-EDTA treatment. To 
prepare 200 mL 10X trypsin-EDTA solution, 1.0 g trypsin, 0.4 g EDTA tetrasodium salt and 1.8 g 
sodium chloride (NaCl) were dissolved in MilliQ water. The solution was sterile filtered and 
stored in 10 mL-aliquot at -200 C. 
 
2.2.2. Cell culture 
LLC-PK1 cells were grown in Medium 199 with HEPES modification supplemented with 2.2 g/L 
NaHCO3, 50 mg/L penicillin G, 50 mg/L streptomycin and 4% fetal calf serum (FCS) (from Fischer 
Scientific). Each flask of cells contained 15 mL of media mix. The cells were incubated at 370 C in 
the presence of 5% CO2. The media was changed every 2-3 days until confluence. At the point 
of confluence, old media was discarded completely and cells were released by 10X trypsin-EDTA 
solution for 10-15 min in the incubator. Once the cells were released, 0.1-0.2 mL cell 
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suspension was used to make new culture flask and the remaining cells were used for growing 
cells in 100-mm culture plates. Each plate contained 10 mL of media mix and 0.4 mL of FCS 
along with cells. 
CCRF-CEM human lymphocytic leukemia cells were cultured in suspension (0.5  106 to 1.0  
106 cells per mL) in RPMI 1640 medium supplemented with 10% FCS. Once the cell density 
reached to 0.5 – 1.0 x 106 cells per mL, cells were subdivided by dilution in new media (CCRF-
CEM). 
 
2.3 Synchronization of CCRF-CEM cells at G1 and G2/M phases 
To synchronize CCRF-CEM cells at G1 phase, cells were grown in RPMI medium supplemented 
with 2.0 g/L NaHCO3, 50 mg/mL penicillin, 50 mg/L streptomycin and 10% fetal calf serum (FCS). 
When the cell density reached about 5.0 x 105 cells per mL, 2.0 mM thymidine was added to 
each plate of cells. Prior use, thymidine was dissolved in purified MilliQ water and the solution 
was then sterile filtered. The cells were incubated with 2.0 mM thymidine for 24 hours. 
Following the incubation, the cell synchronization at G1 phase was confirmed using Flow 
Cytometry. 
To block CCRF-CEM cells at G2/M phase, each plate of cells was incubated with 100 ng/mL 
nocodazole after the cell density reached 5.0 x 105 cells per mL. Following 24 hours of 
incubation, cells were sorted using a flow cytometer to confirm the synchronization at G2/M 
phase. 
 14 
 
2.4 Cell counting 
LLC-PK1 and CCRF-CEM cells were counted using a hemacytometer. In case of LLC-PK1 cells, the 
culture medium from one plate of confluent of cells (ca. 107 cells) was discarded and the cells 
were then incubated with 450 µL of 10X trypsin-EDTA solution for 10-15 min at 370 C. 1 mL of 
DPBS was added to the released cells following trypsin-EDTA incubation. Cells were then 
transferred to a centrifuge tube containing 550 µL horse serum to make the final volume of 2 
mL (450 µL trypsin-EDTA + 1 mL DPBS + 550 µL horse serum) and mixed very well. 10 µL of cells 
was then transferred to an eppendorf tube and diluted to 100 µL using DPBS. 10 µL from the 
final cell suspension was placed onto a hemacytometer and the cells were counted. The 
counted number was finally multiplied by the dilution factor and the actual number of cells 
determined. 
For counting CCRF-CEM cells, cells suspended in RPMI media from one plate were transferred 
to a centrifuge tube and mixed very well by inverting the tube. 10 µL of cell suspension was 
then placed onto a hemacytometer and the cells were counted.  
 
2.5 Cell viability assay (Trypan blue exclusion assay) 
2.5.1 Cell viability of LLC-PK1 cells incubated with Newport Green ester (NPGE) 
The culture medium of one plate of LLC-PK1 cells containing 107 cells was completely drained 
off and the cells were incubated with 1 mL of 10X trypsin-EDTA solution for 10-15 min. The 
released cells were collected in a centrifuge tube and washed three times with fresh DPBS and 
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finally resuspended in DPBS. Cells were then incubated with 10 µM NPGE for an hour at 25 
0C. 
One hour later, 104 cells were reacted with 0.4% Trypan Blue solution in 1:1 ratio and viable 
cells were counted immediately using a hemacytometer. Trypan blue is a dye which can 
penetrate the compromised cell membrane of a dead cell and the cell will in turn look blue 
under the hemacytometer, while the living cells will appear colorless as Trypan blue is not able 
to permeate through the cell membrane of an intact cell.68-70   The cell viability assay was also 
used with LLC-PK1 cells suspended in culture medium. 
 
2.5.2 Cell viability assay of CCRF-CEM cells blocked at G1 and G2/M phases 
Following 24 hours of incubation of CCRF-CEM cells with 2 mM thymidine or 100 ng/mL 
nocodazole, 10 µL cell suspension was taken in an Eppendorf tube and was mixed with 10 µL 
0.4% Trypan Blue solution. The viable cells were counted immediately using a hemacytometer. 
Trypan blue exclusion assay was also performed for control cells, which were treated with 
neither thymidine nor nocodazole.  
 
2.6 Flow cytometry of CCRF-CEM cells blocked at G1 and G2/M phases 
CCRF-CEM cells were incubated with 2 mM thymidine or 100 ng/mL nocodazole for 24 hours. 
Following incubation, synchronized and control (untreated) cells were transferred to centrifuge 
tubes, spun down and the extracellular medium was discarded. Cells were then washed twice 
with Flow Cytometry staining buffer (FACS buffer) prepared by mixing Dulbecco’s phosphate 
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buffered saline (DPBS), 5% fetal calf serum (FCS) and 0.1% sodium azide. Cells were 
resuspended in 70% ethanol while vortexing tube and stored at -200 C. On the day of run, 
stored cells were pelleted for 10 min at 3400 rpm, washed twice with FACS buffer and 
resuspended in 500 µL FACS buffer. In order to eliminate the staining of double stranded RNA 
(dsRNA), 500 µg/mL RNase A was added to the cells. Cells were then incubated for 20 min at 
room temperature. After incubation, cells were again pelleted and resuspended in 500 µL FACS 
buffer. Prior to running cells on flow cytometer, 10 µL of 4’,6’-diamidino-2-phenylindole (DAPI) 
from 1 mg/mL stock solution (in DMF) was added to both control and synchronized cells. Flow 
cytometry of the cells was performed on a BD FACSAria III, DIVA version 6.1.3. 
 
2.7 Fluorescence Spectroscopy of LLC-PK1 Cells   
2.7.1 Fluorescence spectroscopy of LLC-PK1 cells incubated with Newport Green ester (NPGE) 
Cultured cells were grown in 100-mm culture plates until confluence was attained. Culture 
media was discarded and the plates washed three times with cold cholate buffer, prepared by 
dissolving 2.47 g Na2HPO4, 0.53 g NaH2PO4, 17.0 g NaCl and 13.33 g choline chloride in 2 L 
MilliQ water.  Cells were then gently scraped from the plates with a rubber cell scraper and 
pooled in Dulbecco’s phosphate buffered saline (DPBS) (0.1 g/L MgCl2.6H2O, 0.2 g/L KCl, 0.2 g/L 
KH2PO4, 8.0 g/L NaCl, 1.15 g/L anhydrous Na2HPO4).  Cells were collected by centrifugation at 
680 g for 5 min and resuspended in 10 mL DPBS.  The cell suspension was then transferred to a 
cuvette and treated with 10 µM Newport Green ester (NPGE) and incubated in the dark for one 
hour at 25 0C.  For comparison, experiments were also conducted at 37o C.  Then, over a 45 min 
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period and using an excitation wavelength of 505 nm, emission spectra were recorded between 
515 nm and 600 nm with a Hitachi F-4500 fluorescence spectrophotometer.  Afterwards, 10 µM 
N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN) was added and the fluorescence 
spectrum monitored for another 15 min.  Finally, the reaction mixture was centrifuged using a 
microcentrifuge for about 1 min at 290 g to separate the extracellular medium and the cells, 
followed by resuspension  of the cells in 1 mL DPBS. 
 
2.7.2 Fluorescence spectroscopy of LLC-PK1 cells incubated with Zinpyr-1 (ZP1) 
Harvested LLC-PK1 cells were suspended in DPBS and an aliquot of 1 mL cell suspension (ca. 10
7 
cells) was transferred to a cuvette.  Cells were then incubated with 10 µM ZP1 for 15 min. Using 
an excitation wavelength of 515 nm, emission spectra were recorded between 520 nm and 600 
nm. Subsequently, 30 µM TPEN was added for 15 min and fluorescence spectrum observed. In a 
separate experiment, 30 µM ethylenediaminetetraacetate (EDTA) was added to cells for 15 min 
following incubation with 10 µM ZP1 for 15 min. 
 
2.7.3 Fluorescence spectroscopy of LLC-PK1 cells incubated with Zinquin or TSQ followed by 
diethylamine NONOate (DEA-NO) 
LLC-PK1 cells were harvested and resuspended in DPBS. An aliquot of 1 mL cell suspension (ca. 
107 cells) was placed in a cuvette and treated with 20 µM Zinquin ethyl ester or TSQ and 
incubated for 30 min at 25 0C followed by 500 µM DEA-NO for another 25 min. Using an 
excitation wavelength of 370 nm, emission spectra were recorded between 400 nm and 600 
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nm.  Afterwards, 10 µM TPEN was added and the fluorescence spectrum monitored for another 
10 min.   
2.7.4 Fluorescence spectroscopy of CCRF-CEM cells synchronized in G1 phase incubated with 
TSQ or Zinquin 
Cultured CCRF-CEM cells were grown in 100-mm culture plates. When the cell density reached 
about 5.0 x 105 cells per mL, 2 mM thymidine was added to each plate. Following 24 hours of 
incubation, cells suspended in RPMI medium were transferred from culture plates to a 50-mL 
centrifuge tube. Cells were then spun down and the medium discarded. Cells were washed 
twice with DPBS and finally resuspended in fresh DPBS. An aliquot of 1 mL cell suspension (ca. 
1-2 x 107 cells) was placed in a cuvette and treated with 20 µM TSQ or Zinquin for 20-25 min at 
250 C. Using an excitation wavelength of 370 nm, emission spectra of the cell suspension were 
recorded between 400 nm and 600 nm. The protocol was repeated for the control experiment, 
namely, fluorescence spectroscopy of untreated cells with TSQ or Zinquin. 
 
2.8 Isolation of cell lysate following incubation of cells with sensor (and DEA-
NO) and its fractionation using gel filtration column or Centricon filtration 
2.8.1 Preparation of Sephadex G-75 gel filtration column 
Sephadex G-75 beads (4-5 g per gel filtration column) purchased from GE Healthcare were 
soaked in 20 mM Tris buffer (pH 7.4) for 24 hours. Following on, soaked beads were degassed 
for an hour and then slowly packed in glass columns to make 0.7 cm x 80 cm Sephadex G-75 gel 
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filtration columns. Columns were washed with degassed 20 mM Tris buffer (pH 7.4) each time 
before use. 
2.8.2 Isolation of cell lysate following incubation of cells with sensor (and DEA-NO) 
Following incubation of LLC-PK1 or CCRF-CEM (control or synchronized) cells with NPGE or ZP1 
or ZQ/TSQ  DEA-NO, cell suspensions were centrifuged at 640 g to separate the pellet from 
the extracellular medium and to remove extracellular sensors. Cells were further washed twice 
with fresh DPBS to get rid of any residual extracellular sensors. The last cell pellet was 
resuspended in 1 mL of cold MilliQ water.  Cells were then lysed by sonication and centrifuged 
at 47,000 g for 20 min at 4o C to collect the cell supernatant or cell lysate.  
 
2.8.3 Fractionation of the cell lysate using Sephadex G-75 gel filtration column or Centricon 
filtration 
The cell lysate collected as above was either loaded onto an 80 cm  0.75 cm gel filtration 
column of Sephadex G-75 (GE Healthcare) equilibrated with 20 mM Tris buffer (pH 7.4) at room 
temperature or filtered through a Millipore Centricon Centrifuge filter (3K MW cut off) at 4o C 
by centrifugation at 13000 rpm for 30 min to separate the high and low molecular weight 
fractions.  During gel-filtration chromatography, the column was eluted with degassed 20 mM 
Tris-Cl (pH 7.4) and ninety (for NPGE incubated cells) or sixty (for ZP1 or TSQ or ZQ incubated 
cells) fractions were collected.  Emission spectra of all fractions were obtained as described 
above. The zinc content in each fraction was also detected by flame atomic absorption 
spectroscopy (AAS). 
 20 
 
2.9 Isolation of Proteome Using Sephadex G-75 Chromatography  
LLC-PK1 or CCRF-CEM cells were harvested as described above and finally resuspended in 1 mL 
cold MilliQ water. Cells were then lysed by sonication and centrifuged at 47,000 g for 20 min to 
collect the cell supernatant, which was then loaded onto a Sephadex G-75 column equilibrated 
with degassed 20 mM Tris buffer (pH 7.4).  The supernatant was eluted with degassed 20 mM 
Tris-Cl (pH 7.4) and 1 mL fractions were collected.  Fractions within the high molecular weight 
region having absorbance at 280 nm were pooled.  These pooled fractions were referred to as 
the proteome. Proteome was stored in 1 mL aliquots at -800 C until use. On the day of 
experiment, proteome was slow ice-thawed. 
 
2.10 Reaction of isolated proteome with fluorescent sensors 
Frozen proteome was ice-thawed and transferred to a cuvette. Proteome was then incubated 
with the fluorescent sensor (NPG, ZP1, TSQ, Zinquin, FluoZin-3) for a certain time depending on 
the type of sensor. The progress of the reaction was monitored by recording emission spectrum 
at a certain time interval. Upon completion of the reaction, the final reaction mixture was 
fractionated using either Sephadex G-75 gel filtration column or Centricon filtration in order to 
determine the location of the fluorescent species. In case of Sephadex G-75 gel filtration, the 
sample was eluted with degassed 20 mM Tris buffer (pH 7.4) and sixty fractions were collected. 
All the fractions were analyzed for both fluorescence, and zinc content using flame atomic 
absorption spectrophotometry. 
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2.11 BioRad DC Protein Assay 
The protein concentration was measured using a BioRad DC Protein Assay kit; 2.0 mg/mL 
bovine serum albumin (BSA) served as the standard. Prior to the measurement of the sample 
protein concentration, a calibration curve was made using six standard protein concentrations 
ranging from 2.0 mg/mL to 0.0625 mg/mL prepared by serial dilution. 25 µL of each of the 
standards and a blank (Tris buffer only) were mixed with 125 µL alkaline copper tartarate and 1 
mL dilute Folin reagent.71, 72 Upon mixing, the solutions were then incubated for 15 min at room 
temperature. Following incubation, the absorbance at 750 nm of each of the standards and 
blank was recorded using a UV-Visible spectrophotometer. The absorbance at 750 nm was 
plotted against the concentrations of the standards to make the calibration curve. To measure 
the concentration of the protein sample, the above mentioned protocol was followed and the 
recorded absorbance was compared with the calibration curve. 
 
2.12 Isolation of subcellular proteomes from LLC-PK1 cells  
Subcellular proteomes were isolated as described with modifications.73 LLC-PK1 cells were 
collected and resuspended in 4 mL of pre-chilled homogenation buffer (0.25 M sucrose, 15 mM 
KCl, 1.5 mM MgSO4, and 10 mM Tris-Cl pH 7.4). The cell suspension was then homogenized 
using a pestle and centrifuged at 1,000 g for 10 min at 4o C.   The pellet was saved as the 
nominal membrane-nuclear fraction.  Supernatant was then centrifuged at 10,000 g for 15 min 
at 4o C.  The pellet was retained as the mitochondrial fraction. Supernatant was centrifuged 
again at 100,000 g at 4o C and the resultant supernatant was designated the cytosolic 
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proteome.  The membrane-nuclear and mitochondrial fractions were sonicated and centrifuged 
at 47,000 g for 20 min at 4 0C and the resultant supernatants were labelled as 
‘membrane/nuclear and mitochondrial proteomes, respectively. The protein concentrations of 
all three fractions were measured using BioRad DC protein assay. Subcellular proteome samples 
were stored at -800 C, if not used immediately after isolation. On the day of experiment, the 
frozen samples were slowly ice-thawed. 
 
2.13 Reaction of LLC-PK1 cells with Zn(pyrithione)2 in the presence of Newport 
Green (NPGE) 
Harvested and washed LLC-PK1 cells were resuspended in 1 mL DPBS and transferred to a 
cuvette. Cells were then incubated with 10 µM NPGE for 30 min while monitoring the progress 
of the reaction by recording the emission spectrum. 30 min later, the cell suspension was 
centrifuged at 640 g for 5 min and the supernatant was discarded. The cell pellet was washed 
twice with DPBS to remove any residual extracellular NPG and resuspended in 1 mL DPBS. 
Following wash, the emission spectrum of the cell suspension was recorded for another 10 min. 
Cells were then reacted with a pre-incubated mixture of 10 µM ZnCl2 and 2 µM pyrithione for 
20 min. Change of fluorescence was recorded upon addition of Zn(pyrithione)2. Subsequently, 
10 µM EDTA was added for 10 min followed by 10 µM TPEN for another 10 min. 
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2.14 Reaction of model Zn-proteins (alcohol dehydrogenase, carbonic 
anhydrase) with Newport Green or Zinpyr-1 
The solutions of the model Zn-proteins, such as alcohol dehydrogenase and carbonic 
anhydrase, were prepared by dissolving the lyophilized powder of the Zn-proteins in degassed 
20 mM Tris buffer (pH 7.4). The zinc concentration of the protein solutions were measured 
using flame AAS. Zn-protein solutions were incubated with Newport Green (acid or ester) or 
Znpyr-1 and the progress of the reaction was monitored by recording emission spectrum. To 
identify the fluorescent species, the final reaction mixture was fractionated using either 
Sephadex G-75 gel filtration column or Centricon filtration. For Sephadex G-75 gel filtration, the 
sample was eluted with degassed 20 mM Tris buffer (pH 7.4) and 50-60 fractions were 
collected. All the fractions were analyzed for both fluorescence, and zinc content using flame 
atomic absorption spectrophotometry. 
 
2.15 Quantification of Zn2+ by Atomic Absorption Spectrophotometry  
The concentration of Zn2+ in solutions was determined by flame Atomic Absorption 
Spectrophotometry (AAS).  A GBC model 904 instrument employed an acetylene torch to 
atomize samples using an 80:20 mixture of compressed air and acetylene.  Zinc measurements 
were made with deuterium background correction.  The instrument was calibrated before each 
run using three standard Zn2+ solutions of 0.5 ppm, 1.0 ppm and 2.0 ppm. The calibration curve 
was not considered acceptable until the maximum error was 0.2 µM or less.  
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2.16 Quantification of sulfhydryl groups in proteome 
The concentration of sulfhydryl groups was determined with Ellman’s Reagent or 5, 5’-dithiobis-
2-nitrobenzoic acid (DTNB).74 To prepare a 10 mM DTNB stock solution, 25 mL MilliQ water was 
added to 0.1 g DTNB solid. The mixture was gently stirred. Because DTNB is insoluble at acid pH 
but oxidizes immediately at pH greater than 8.0, the pH of the solution was monitored while 
being stirred. Since the pH was around 3.0 to start out and little DTNB powder was in solution, a 
few crystals of Trizma (Tris) base was added until the pH was between 6.5 and 7.0. The solution 
was then filtered to remove the residual amount of undissolved DTNB. The filtered DTNB 
solution was kept into a small brown bottle and stored in dark. The color of the solution was 
pale yellow. 
 For measurement of sulfhydryl concentrations of proteome samples, 60 µL of proteome 
sample was diluted with 540 µL 20 mM Tris-Cl, pH 7.4. 60 µL of 10 mM DTNB was then added to 
the sample and vortexed immediately. The solution was incubated in dark for 30-60 min before 
the absorbance at 412 nm was obtained. An extinction coefficient of 13,600 cm-1M-1 was used 
to determine the concentration of reactive thiol groups in the samples. 
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3. RESULTS 
3.1 Chemical Biology of Newport Green (NPG) 
Newport Green (NPG) is a fluorescent zinc sensor with relatively low stability constant for Zn2+ 
(Kd  10
-5 – 10-6 M).1, 46 A number of studies have used this sensor to image intracellular mobile 
Zn2+ and revealed various physiological roles of Zn2+ based on the spectral properties of 
Newport Green.75-80 Upon binding Zn2+, NPG displays an enhancement of fluorescence at 530 
nm. Typically, the fluorescence enhancement following the incubation of cells with NPG is 
linked with the intracellular Zn-NPG formation (reaction 3.1). However, the possibilities of other 
reactions of NPG with the cellular constituents are often ignored. For example, like TSQ and 
Zinquin, NPG may react with cellular Zn-proteins to generate ternary adduct species NPG-Zn-
Protein (reaction 3.2).23, 65 
Zn2+ + NPG ⇌ Zn-NPG            (3.1) 
Zn-Protein + NPG ⇌ NPG-Zn-Protein            (3.2) 
Moreover, due to its low stability constant for Zn2+, NPG may have to compete with other 
potential cellular ligands for Zn2+, including proteome and small molecules. Therefore, its ability 
to effectively image intracellular Zn2+ will depend on the stability of Zn-NPG in the presence of 
other cellular competitors of Zn2+. This present work examines how effectively NPG can serve as 
an intracellular zinc sensor. 
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3.1.1. Spectral properties of NPG and Zn-NPG 
The ester form of Newport Green, NPGE, does not fluoresce but gains its fluorescent property 
upon conversion to its acid form, NPGA, catalyzed by cellular esterase.  With excitation at 505 
nm, NPGA emitted fluorescence with a wavelength maximum at 530 nm. However, the 
fluorescence of NPGA and Zn-NPGA were not linearly dependent on their concentration (Figure 
3.1.1). With increasing concentration, their fluorescence intensity increased non-linearly until a 
maximum value after which it declined.  Moreover, the emission wavelength maximum 
changed with concentration. The declining fluorescence intensity of NPGA and Zn-NPGA at 
higher concentration might be due to the stacking of fluorescein, the reporter part of NPG.    
Regardless of the cause, this property of NPGA makes it difficult to quantify the actual Zn
2+ 
concentration simply from the observation of its fluorescence response. When titrated with 
Zn2+, NPGA formed a 1:1 complex with its emission wavelength maximum unaltered and about 
twice the intensity of the free ligand (Figure 3.1.2 and 3.1.3).  The product rapidly reacted with 
TPEN, a cell permeant, high affinity chelator of Zn2+, returning the fluorescence to that of NPGA 
(Figure 3.1.3).  
 
3.1.2. Cell viability  
As the cellular experiments in this study were performed in DPBS buffer at 25 0C for an hour or 
so, the cell viability was determined under such conditions using the Trypan Blue exclusion 
assay. Cell viability under experimental conditions was calculated to be 90%, whereas cells kept 
in complete culture medium were found to be almost 100% viable.  
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Figure 3.1.1 Change of fluorescence intensity and emission wavelength maximum of NPGA 
and Zn-NPGA with increasing concentration: Equivalent amounts of NPGA and ZnCl2 were mixed 
to make Zn-NPG complex. The numbers under each data point indicate the emission 
wavelength maximum of each spectrum in nanometers. 
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Figure 3.1.2 Titration of NPG with Zn2+: 10 µM NPGA in 20 mM Tris (pH 7.4) was titrated with 
the increasing concentration of ZnCl2 at 25
o C. Following each addition of ZnCl2, the sample was 
excited at 505 nm and fluorescence spectrum was read in the range of 515 – 600 nm. The 
maximum fluorescence intensity of each titration point was plotted against the total 
concentration of the added Zn2+. 
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Figure 3.1.3 Fluorescence spectra of NPG, Zn-NPG and the quenching by TPEN:  10 µM NPGA in 
20 mM Tris (pH 7.4) was incubated with 10 µM ZnCl2 at 25
o C. Subsequently, 10 µM TPEN was 
added to the solution. The sample was excited at 505 nm and the fluorescence spectra were 
read in the range of 515 – 600 nm. 
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3.1.3 Reaction of NPGE with LLC-PK1 cells 
 As a basis for addressing the question of what NPG images in cells, the reaction of NPGE with 
107 LLC-PK1 cells in DPBS buffer was monitored by spectrofluorimetry at 25
o and 37o C.  At 25oC, 
fluorescence intensity increased slowly at 530 nm, reaching a maximum after 40 min, indicative 
at least of the conversion of some NPGE to NPGA catalyzed by cellular esterases (Figure 3.1.4).  
The background fluorescence of media and cells was insignificant in comparison with the 
fluorescence contributed by the formation of NPGA (Figure 3.1.5B). Considering the initial 
extracellular concentration of NPGE, complete hydrolysis of the sensor would result in an 
intensity of about 5000 arbitrary units.  Since the observed, maximal fluorescence was only 
about 1200 units, at most about 25% of NPGE had undergone reaction during this period. At 
that point, TPEN was added to quench the fluorescence of any Zn-NPGA that had formed.  No 
reduction in fluorescence emission was observed over a period of 20 min, leading to the 
conclusion that detectable Zn-NPGA had not been produced in these cells.  Since TPEN forms 
ternary adducts with Zn-proteins, the results also suggested that NPGA had not formed NPG-Zn-
protein species that could be converted to TPEN-Zn-proteins.67 
The reaction of NPGE with 10
7 LLC-PK1 cells at 37 
oC was qualitatively similar to the one at 25o C 
though as expected it proceeded at a faster rate (Figure 3.1.4). Moreover, treatment of cells 
with TPEN prior to addition of NPGE failed to modify the reaction, confirming the lack of 
interaction of NPG with intracellular Zn2+. Although the formation of Zn-NPGA was not 
supported at either temperature, it remained possible that ternary adducts of NPGA-Zn-
proteins accounted for some of the fluorescence increase, and were unreactive with TPEN. 
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Figure 3.1.4 Reaction of LLC-PK1 cells with NPGE. 10
7 LLC-PK1 cells suspended in 1 mL DPBS 
were treated with 10 µM NPGE for 40 min at 25
oC. Subsequently, 10 µM TPEN was added for 
another 20 min. The reaction was repeated at 37oC. In the third case, 107 LLC-PK1 cells were 
pre-incubated 10 µM TPEN for 20 min at 25oC followed by the treatment with 10 µM NPGE for 
another 40 min.  
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After the reaction, the cell suspension was centrifuged to separate the extracellular medium 
and cells, which were then resuspended in DPBS.  Surprisingly, most of the fluorescence (about 
70%) was found in the external medium (Figure 3.1.5A), and it could not be quenched by the 
addition of 10 µM TPEN for 5 min (Figure 3.1.6).  To investigate this surprising result, 2.7  107 
cells/mL were incubated with 10 µM NPGE in DPBS at 25 
oC for 40 min followed by fluorescence 
emission analysis.  The suspension (1) was centrifuged to produce extracellular supernatant (a), 
and the cells (2) were then resuspended in 1 mL of NPGE-free medium for 20 min.  After a 
fluorescence measurement, supernatant (b) was isolated.  The relative fluorescence emission 
properties of both suspensions and supernatants were determined.   According to Figure 3.1.7, 
most of the fluorescence was found in the extracellular part of the first cell suspension (a) and a 
significant fraction of the external medium of the second cell suspension (b).  Since cell 
suspension 2 began its incubation with only intracellular NPGA and perhaps some NPGE, the fact 
that fluorescence made its way into the external medium demonstrated that NPGA underwent 
efflux from the cells during the 20 min period.  
We considered the possibility that during the initial isolation of cells via scraping some cells 
were damaged resulting in progressive release of intracellular esterase activity and/or NPG into 
the external medium. However, we repeated this experiment with CCRF-CEM cells, a cell line 
that grows in suspension culture, and did not require scraping and obtained the same result 
(Figure 3.1.8), ruling out the possibility that scraping had resulted in the appearance of NPGA in 
the extracellular medium.   
These findings are consistent with two hypotheses, either (i) NPGE is accumulated by cells and 
undergoes internal esterase hydrolysis to NPGA which is then transported out of the cells or (ii) 
 33 
 
NPGE both moves into cells and is hydrolyzed on the extracellular surface of the cell.  In the 
absence of extracellular NPGE, the ester leaves the cell and undergoes ester hydrolysis.  In 
either case, the interaction of NPG with cells is considerably more complicated than anticipated 
and results in most of the detectable sensor (NPGA) residing in the external medium. 
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A. 
 
B. 
 
Figure 3.1.5 Reaction of LLC-PK1 cells with NPGE. (A) 10
7 LLC-PK1 cells suspended in 1 mL DPBS 
were treated with 10 µM NPGE for 40 min at 25
oC. Subsequently, 10 µM TPEN was added for 
another 20 min.  The reaction mixture, after 1 h, was centrifuged at 290 g and the extracellular 
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medium separated from the cells. The cells were resuspended in 1 mL DPBS. Error bar 
represents standard error for three measurements. (B) Background fluorescence of 
extracellular medium (DPBS), and 107 LLC-PK1 cells suspended in DPBS at 25
o C. 
 
 
 
 
Figure 3.1.6 TPEN effect to the extracellular fluorescence: Reaction of TPEN with the 
extracellular medium separated from the reaction of 107 LLC-PK1 cells with 10 µM NPGE for an 
hour at 25o C. 10 µM TPEN incubated for 5 min. 
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Figure 3.1.7 Efflux of NPGA from cells.  2.7  10
7 LLC-PK1 cells were reacted with 10 µM NPGE 
for 40 min.  The reaction mixture was centrifuged to separate the extracellular medium and 
cells. The cells resuspended in 1 mL DPBS were incubated for another 20 min and then 
centrifuged again to separate the extracellular medium and cells, which were then resuspended 
in 1 mL DPBS.  
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Figure 3.1.8 Reaction of CCRF-CEM cells and NPGE: (A) Reaction of 2 x 10
7 CCRF-CEM cells 
suspended in DPBS at 25o C and 10 µM NPGE for about 40 min followed by the addition of 10 
µM TPEN for another 20 min (arrow). (B) After one hour, the final reaction mixture was 
centrifuged to separate extracellular medium and cell pellet. Cell pellet was subsequently 
resuspended in 1 mL DPBS.  
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3.1.4 Location of NPGA among cell constituents.  
To characterize the intracellular properties of NPGA, cells isolated after one hour incubation 
with NPGE were lysed and the supernatant subjected to Sephadex G-75 chromatography.  
Proteome and low molecular weight fractions were assayed for Zn2+ and fluorescence.  Zn2+ was 
associated with the high molecular weight proteome fractions, whereas fluorescent NPGA 
emerged from the column without bound Zn2+ well beyond the total volume of the column 
indicative of a favorable interaction between the Sephadex beads and NPGA (Figure 3.1.9). 
Possibly, the chromatographic separation altered the original supernatant distribution.  To 
investigate this possibility, proteome and low molecular weight species were separated using 
the Centricon filtration system and a 3 kDa cut-off filter. The majority of NPGA (about 85% of 
total fluorescence intensity) was retained by the filter during centrifugation along with the 
proteome (Figure 3.1.10).  Thus, NPGA was weakly associated with protein in the supernatant 
but was dissociated from the proteome during Sephadex chromatography.   
 
3.1.5 Reaction of NPGE and NPGA with isolated proteome. 
In order to gain a more detailed understanding of the reaction of NPG with cells, an analogous 
set of experiments was conducted using isolated supernatant or proteome in place of whole 
cells.  NPGE was slowly hydrolyzed to NPGA by supernatant or proteome, indicative of the 
presence of proteomic esterases that catalyze this conversion (Figure 3.1.11).  As in cells, much 
of the NPGA (84% of total fluorescence intensity) that was generated became associated with 
the proteome as shown by centrifugal filtration. The addition of TPEN failed to quench the 
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proteome-associated fluorescence (Figure 3.1.12), consistent with the conclusion that NPGA-Zn-
proteins did not form during the enhancement of fluorescence.   
NPGE     NPGA 
Proteome + NPGA     ProteomeNPGA 
 
 
 
 
Figure 3.1.9 Interaction of NPGA with Sephadex beads: Proteome (10 µM Zn
2+) in 20 mM Tris 
(pH 7.4) was reacted with 10 µM NPGA for 15 min at 25
o C followed by Sephadex G-75 filtration 
of the final reaction mixture. The eluted fractions were analyzed for both fluorescence and zinc.  
Arrow shows total volume of the column. 
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Figure 3.1.10 Centricon filtration of the reaction mixture of proteome and NPGA: 2.5  10
8 LLC-
PK1 cells suspended in DPBS were reacted with 10 µM NPGE for an hour in the dark. The cells 
were then washed three times to remove the extracellular NPG and resuspended in MilliQ 
water. Following sonication and centrifugation, the cell lysate was filtered using the Centricon 
filtration system and a 3kDa cut-off filter to separate high molecular weight (retentate) and low 
molecular weight (flow through) components. 
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Figure 3.1.11 Reaction of proteome with NPGE. 4.2 mg/mL proteome in 20 mM Tris pH 7.4 
containing 7 µM Zn2+ was incubated with 10 µM NPGE at ambient temperature (ca. 23
o C) for 90 
min. Fluorescence spectra were read every 15 min. The inset shows the progress of reaction 
with time. 
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 Figure 3.1.12 Centricon filtration of the reaction mixture of proteome and NPGE. 4.2 mg/mL 
proteome in 20 mM Tris pH 7.4 containing 7 µM Zn2+ was incubated with 10 µM NPGE at 
ambient temperature (ca. 23o C) for 90 min. The final reaction mixture was separated by 
Centricon filtration using 3K cut-off filter into the high molecular weight retentate and the low 
molecular weight filtrate. 10 µM TPEN was added for 5 min to both retentate and flow through 
fractions. 
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3.1.6 Reactions of NPG with model Zn-proteins (alcohol dehydrogenase, carbonic anhydrase).  
The cellular and proteomic experiments with NPG indicate that the sensor does not successfully 
compete for native, proteomic Zn2+.  But they do not exclude the possibility that NPG may form 
ternary adducts with Zn-proteins that are insensitive to the presence of TPEN.  To address this 
issue,  NPGE was reacted with two model Zn-proteins, alcohol dehydrogenase and carbonic 
anhydrase, that are known to form TPEN-sensitive ternary adducts with the Zn2+ sensors, TSQ 
and/or Zinquin (ZQ).50, 65  Upon incubation of NPGE with Zn-ADH, the fluorescence gradually 
increased with time (Figure 3.1.13 A). However, TPEN was unable to quench the fluorescence. 
Therefore, the fluorescence increase was indicative of the capacity of ADH to act upon NPGE as 
an esterase not the ability of NPG to associate with one of ADH’s bound Zn2+ ions.  ZQ removes 
1 Zn2+ from this protein as Zn(ZQ)2 and binds to the other to form a fluorescent adduct.
50  Both 
are quenched by TPEN as it acquires Zn2+ from Zn(ZQ)2 and displaces ZQ from ZQ-Zn-ADH to 
form TPEN-Zn-ADH.50  Together with this information, the current result strongly implies that 
NPG neither binds to nor extracts Zn2+ from this protein.  Similar results were obtained with Zn-
CA; the protein has NPGE esterase activity but is otherwise unreactive with NPG (Figure 3.1.14 
A). Nevertheless, the majority of NPGA did associate with Zn2-ADH and Zn-CA according to 
Centricon filtration analysis (Figure 3.1.13 B and 3.1.14 B). 
 
 
 
 
 44 
 
A. 
 
B. 
 
Figure 3.1.13 Reaction of alcohol dehydrogenase (ADH) with NPGE. (A) 2 µM alcohol 
dehydrogenase was incubated with 10 µM NPGE at ambient temperature (ca. 23
o C) for 90 min. 
(B) Separation of the final reaction mixture by Centricon filtration using 3K cut-off filter.  
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A. 
 
B. 
 
Figure 3.1.14 Reaction of carbonic anhydrase (CA) with NPGE. (A) 10 µM carbonic anhydrase 
was incubated with 10 µM NPGE at ambient temperature (ca. 23
o C) for 90 min. (B) Separation 
of the final reaction mixture by Centricon filtration using 3K cut-off filter.  
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3.1.7 Stability of Zn-NPGA with proteome.  
It was evident that NPGA cannot compete with native, protein bound Zn
2+ to form Zn-NPGA.  We 
then inquired whether it can compete for adventitiously bound Zn2+ that might be produced 
under certain physiological or pathological conditions.  Initially, 10 µM Zn-NPGA was titrated 
with proteome to test whether this species exhibits stability in the presence of protein 
competitors for Zn2+.  Figure 3.1.15 shows that addition of proteome up to about 50 µg 
protein/mL (0-170 nM Zn2+ bound as Zn-protein) reduced the starting fluorescence intensity of 
Zn-NPGA to that of an equivalent concentration of NPGA.  Thus, NPGA does not compete 
favorably with proteome for Zn2+.   
Zn-NPGA  +   Proteome   Proteome Zn  + NPGA 
The capability of NPGA to compete with proteome for Zn
2+ was probed another way:  4.2 
mg/mL proteome containing 7 µM Zn-proteins was mixed with 10 M NPGA initially in 20 mM 
Tris (pH 7.4) and then titrated with Zn2+ (Figure 3.1.16).  NPGA fluorescence did not increase 
until Zn2+ reached 30-35 μM or about 5x the total proteomic concentration of Zn2+.  At higher 
concentrations of Zn2+, fluorescence emission at 535 nm increased; but even at 100 μM Zn2+, 
stoichiometric Zn-NPGA had not been generated, showing that proteomic sites continued to 
partially sequester Zn2+ even at these large concentrations.  Both experiments demonstrated 
that under the described conditions, NPGA has little, if any, capacity to compete with native 
proteome for Zn2+ that might be liberated from cellular binding sites during physiological or 
pathological processes.   
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Figure 3.1.15 Stability of Zn-NPGA in the presence of proteome. 10 µM Zn-NPGA complex was 
titrated with the increasing concentration of proteome isolated from LLC-PK1 cells. Following 
each addition of proteome, the fluorescence spectrum was recorded. The maximum 
fluorescence intensity was plotted against the total concentration of proteome. The dilution of 
the sample by 100 µg/mL proteome was only 2% and was ignored. The red square indicates the 
baseline fluorescence of 10 µM NPGA. 
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Figure 3.1.16 Titration of proteome with ZnCl2 in the presence of NPGA. 4.2 mg/mL proteome 
(7 µM Zn2+ content) isolated from LLC-PK1 cells was titrated with ZnCl2 in the presence of 10 µM 
NPGA. The reaction was performed in 20 mM Tris buffer at pH 7.4. Following each addition of 
ZnCl2, the fluorescence spectrum was recorded, and the maximum fluorescence intensity was 
plotted against the total concentration of the added ZnCl2. Control: 10 µM NPGA in 20 mM Tris 
buffer at pH 7.4 was titrated with ZnCl2.  
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We considered the possibility that proteins with substantial zinc buffering capacity might be 
distributed among some organelles and not able to interfere with NPGA’s ability to image free 
or loosely bound Zn2+ in other compartments. To investigate this possibility, 1.7 mg/mL of 
cytosolic proteome (ca. 2.8 µM Zn2+), isolated by gentle homogenization of cells followed by 
centrifugation at 100,000 x g, was mixed with 10 M NPGA and subsequently titrated with Zn
2+ 
(Figure 3.1.17). A detectable increase of fluorescence was not observed until the added Zn2+ 
reached about 10 M.  Beyond that, NPGA partially competed with cytosolic proteome for 
additional Zn2+. This result was in qualitative agreement with the findings with whole proteome 
in the previous experiment and indicated that a subset of proteins within the cytosolic 
proteome possesses substantially higher affinity for free or loosely bound Zn2+ than does NPGA. 
Similar results were obtained with membrane/nuclear and mitochondrial proteomes (Figure 
3.1.17).  All of the compartments displayed substantial Zn2+ buffering capacity. 
 
3.1.8 Stability of Zn-NPGA with Glutathione.   
The stability of Zn-NPGA was also studied in the presence of glutathione (GSH).  GSH exists in 
the cells in mM concentration and displays modest affinity for Zn2+ (104.2. pH 7.2, 25o C).81  As 
little as 30 M of GSH decreased the fluorescence intensity of 10 M Zn-NPGA by almost 80% 
(Figure 3.1.18). The competition of glutathione for Zn2+ with NPGA was also confirmed by the 
titration of NPGA with Zn
2+ in the presence of glutathione (Figure 3.1.19). 
Zn-NPGA  +   Glutathione   Glutathione - Zn  + NPGA 
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Figure 3.1.17 Stability of Zn-NPGA with sub-cellular proteome. 1.7 mg/mL cytosolic proteome, 
1.6 mg/mL mitochondrial proteome and 1.6 mg/mL nuclear proteome were titrated with ZnCl2 
in the presence of 10 µM NPGA. Initially, subcellular proteome was incubated with NPGA for 15 
min. The incubation period of NPGA with the subcellular fractions after each addition of Zn
2+ 
was 5 min. The inset highlights the initial buffering region.  
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Figure 3.1.18 Stability of Zn-NPGA in the presence of glutathione (GSH). 10 µM Zn-NPGA 
complex in 20 mM Tris buffer at pH 7.4 was titrated with the increasing concentration of 
glutathione (GSH). The incubation period after each addition was 5 min. Following each 
addition, the fluorescence spectrum was recorded, and the maximum fluorescence intensity 
was plotted against the glutathione concentration. The dilution of the sample by 40 µM GSH 
was 2%. The red circle indicates the baseline fluorescence of 10 µM NPGA. 
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Figure 3.1.19 Titration of NPGA with ZnCl2 in the presence of glutathione (GSH). 10 µM NPGA in 
20 mM Tris buffer at pH 7.4 was titrated with ZnCl2 in the absence or presence of various 
concentrations of glutathione. Following each addition of ZnCl2, the fluorescence spectrum was 
recorded, and the maximum fluorescence intensity was plotted against the total concentration 
of added ZnCl2. Initially, NPGA was mixed with GSH and for 5 min after each addition of Zn
2+.  
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3.1.7 Reaction of NPG and Zn-NPG with bovine serum albumin (BSA) 
As albumin has a potential zinc binding site,82 10 µM Zn-NPGA was reacted with bovine serum 
albumin (BSA) to test its stability in the presence of BSA. As a control, 10 µM NPGA was reacted 
with 10 µM BSA. Figure 3.1.20 A shows that in control reaction, fluorescence increased by two 
fold and the emission maximum of NPGA shifted significantly from 532 nm to 538 nm 
suggesting the non-specific interaction of NPGA with BSA. BSA also reacted with Zn-NPGA with 
an enhancement of fluorescence and wavelength shift from 532 nm to 538 nm indicative of 
either specific interaction of Zn-NPGA with BSA (BSA-Zn-NPGA) through its zinc binding site or 
non-specific interaction (BSA-NPGA-Zn). Regardless of the mode of interaction, this finding 
further complicates the use of NPG as a cellular sensor, since it may undergo non-specific 
interaction with cellular components. Following Centricon filtration of the final reaction mixture 
using 3K cut-off filter, all the fluorescence was found in the retentate, which confirmed the 
interaction of NPGA with BSA (Figure 3.1.20 B). To extend the understanding of the reaction 
between Zn-NPGA and BSA, 10 µM Zn-NPGA was titrated with the increasing concentration of 
BSA (Figure 3.1.21). Interestingly, fluorescence of Zn-NPGA initially decreased until a minimum 
was reached and increased again at higher concentrations of BSA. In addition, the emission 
maximum changed from Zn-NPG’s 532 nm to final 538 nm. This suggested that at lower 
concentration of BSA, Zn2+ was extracted from Zn-NPGA by BSA, hence the reduction of 
fluorescence was observed. However, at higher concentration of BSA, NPG binds BSA with an 
enhancement of fluorescence and a wavelength shift. 
Zn-NPG + BSA  Zn-BSA + NPG (at lower concentration of BSA) 
BSA + NPG  BSA-NPG (at higher concentration of BSA) 
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A. 
 
B. 
 
Figure 3.1.20 Reaction of NPGA and Zn-NPGA with bovine serum albumin (BSA). (A) 10 µM 
NPG or Zn-NPG in 20 mM Tris buffer at pH 7.4 was reacted with 10 µM BSA for 15 min. (B) 
Centricon filtration of the final reaction mixtures using 3K cut-off filter. 
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A. 
 
B. 
 
Figure 3.1.21 Titration of Zn-NPGA with BSA: (A) 10 µM Zn-NPGA in 20 mM Tris (pH 7.4) was 
titrated with the increasing concentration of BSA. (B) Change of maximum fluorescence 
intensity and emission maximum with increasing concentration of BSA. 
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3.1.9 Response of intracellular NPGA to added Zn
2+.  
The stability of Zn-NPGA within the cellular environment was also investigated.  To do so, 1.5 x 
107 LLC-PK1 cells were reacted with 10 µM NPGE for 30 min followed by washing to remove any 
remaining extracellular medium. The cells resuspended in DPBS were subsequently treated for 
20 min with a pre-incubated mixture of 10 µM ZnCl2 and 2 µM pyrithione, which served as an 
ionophore to conduct Zn2+ into cells.  During this time the internal concentration of Zn2+ 
increased from 1.8 nmoles/107 cells to 2.6 nmoles/107 cells, representing 15% of the added 
Zn2+.  An increase of fluorescence (173% of control) was observed after the addition of Zn-
pyrithione (Figure 3.1.22).  However, 10 µM EDTA rapidly reversed the fluorescence to 104% of 
control suggesting that the elevation in fluorescence was mostly due to the binding of 
extracellular Zn2+ to NPGA that had diffused out of the cells. The inability of 10 µM TPEN to 
quench the remaining fluorescence ruled out the possibility that the residual 4% increase in 
fluorescence originated from binding of added Zn2+ to intracellular NPGA.  Instead, it probably 
arose from the continuing hydrolysis of intracellular non-fluorescent NPGE to fluorescent NPGA.   
Thus, although the intracellular Zn2+ concentration had increased almost 50%, no Zn-NPGA was 
observed in the cells. Therefore, the results indicated that the intracellular NPGA did not 
compete for adventitious Zn2+ within the cellular environment.  
Zn out  Zn in 
Zn in + Proteome + NPGA,in  ProteomeZnin + NPGA,in 
NPGA,in  NPGA,out 
NPGA,out + Zn-pyrout  Zn-NPGA,out + pyrout 
Zn-NPGA,out + EDTA  Zn-EDTA + NPGA,out 
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Figure 3.1.22 Reaction of NPGE incubated LLC-PK1 cells with Zn-pyrithione. 1.5x10
7 cells were 
treated with 10 µM NPGE for 30 min, washed twice and resuspended in DPBS (control). A pre-
incubated mixture of 10 µM ZnCl2 and 2 µM pyrithione was then added for 20 min. Pyr. 
indicates pyrithione. Subsequently, 10 µM EDTA was introduced for 10 min followed by 10 µM 
TPEN for another 10 min. Error bar represents standard error for three measurements.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
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3.1.10 Reaction of proteome with thiol reactive agents NO and NEM in the presence of NPGA   
To further examine if NPGA can image Zn
2+ released from Zn-proteins, 3.6 mg/mL proteome 
containing 12 M Zn-proteins was reacted with 200 M of the nitric oxide donor, diethylamine 
NONOate (DEA-NO) in the presence of 10 µM NPGA. The NO produced from the breakdown of 
DEA-NO can react with sulfhydryl groups in the Zn binding sites of the Zn-proteins resulting in 
the release of Zn2+.27  A 17% increase of fluorescence upon addition of DEA-NO was observed, 
which initially pointed to the release of Zn2+ and the subsequent formation of Zn-NPGA (Figure 
3.1.23). However, the observation that TPEN did not reduce the fluorescence undermined this 
possibility.  As a control, NPGA was reacted with DEA-NO to see if the sensor, itself, underwent 
reaction with DEA-NO.  A 50% increase of fluorescence was observed upon its reaction with 
DEA-NO for 2 hours (Figure 3.1.23).  Apparently, NPGA directly reacts with NO released from 
DEA-NO, resulting in an enhancement of fluorescence. 
NPGA’s weak ability to image adventitious Zn
2+ released from the Zn-proteome was further 
verified with the use of another thiol binding reagent, N-ethylmaleimide (NEM). 5.14 mg/mL 
proteome containing 17 M Zn-proteins was reacted with NEM.  A total of 500 M NEM 
reduced the proteomic thiol concentration by almost 64% (from 352 µM to 125 µM) and caused 
about a 12% increase of fluorescence of 10 µM NPGA, maximally equivalent to the formation of 
about 1 M Zn-NPGA (Figure 3.1.24).  The addition of 30 µM TPEN for 30 min reduced the 
fluorescence to 109% of control.  Thus, no more than 0.3 µM Zn-NPGA had actually formed.  In 
contrast, substituting 20 µM Zinquin for NPGA, the higher affinity zinc sensor displayed a 47% 
increase of fluorescence after addition of only 100 µM NEM to the proteome.  In the process, 
 59 
 
25% of the proteomic zinc (4.2 µM) was labilized by NEM, much of it becoming bound to 
Zinquin.83 
 
 
 
 
 
Figure 3.1.23 Reaction of proteome with diethylamine NONOate (DEA-NO) in the presence of 
NPGA. Proteome (10 µM Zn
2+) isolated from LLC-PK1 cells was reacted with with 200 µM DEA-
NO for 90 min in the presence of 10 µM NPGA followed by the treatment with 10 µM TPEN for 
30 min. The fluorescence was recorded continuously. 10 µM NPGA in Tris was reacted with 200 
µM DEA-NO for 2 hours as a control. Prot. indicates proteome. 
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Figure 3.1.24 Reaction of proteome with N-ethylmaleimide (NEM) in the presence of NPGA. 
Proteome (17 µM Zn2+) was reacted with 500 µM NEM in the presence of 10 µM NPGA for 30 
min. Subsequently, 30 µM TPEN was added for another 30 min. Error bar represents standard 
error for three measurements.   
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3.2 Chemical Biology of Zinpyr-1 (ZP1) 
Having found that Newport Green, a low affinity zinc senor, is unable to form intracellular Zn-
NPG complex by outcompeting proteome’s non-specific Zn2+ binding sites, for comparison, the 
chemical-biological properties of a relatively higher affinity sensor, Zinpyr-1 (ZP1), were studied. 
ZP1 has a dichlorofluorescein as the fluorophore and two appended di-2-picolylamine (DPA) 
moieties as Zn2+ binding ligands (Figure 1.2). Of these two binding sites, one is of higher affinity 
(Kd 0.7 nM) than the second one (Kd 85 µM).
1 Various articles have reported the intracellular 
imaging of Zn2+ by ZP1.84-89 However, due to its high affinity Zn2+ binding site, it may undergo 
other possible reactions. For example, ZP1 may directly react with the native Zn-proteins and 
thus perturb the equilibrium between the bound and the free Zn2+ (reaction 3.2.1).   
 Zn-protein + ZP1 ⇌  apo-protein + ZP1(Zn)2     (3.2.1) 
Moreover, like Zinquin (ZQ) which also has nanomolar stability constant, ZP1 can form ternary 
adduct with specific Zn-proteins and generate ZP1-Zn-Protein ternary adduct (reaction 3.2.2). 
 Zn-protein + ZP1 ⇌  ZP1-Zn-Protein      (3.2.2) 
From Newport Green study, we have seen that proteome possesses a zinc buffering capacity. 
So, ZP1 can also interact with Zn2+ adventitiously bound to various non-specific proteomic sites 
(reaction 3.2.3). 
Proteome + Zn2+ + ZP1 ⇌ ProteomeZn-ZP1       (3.2.3) 
This study investigated all these possible reactions of ZP1 both in vitro and in vivo. 
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3.2.1 Reaction of ZP1 with ZnCl2 
To investigate the spectral properties of ZP1, 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated 
with the increasing concentration of ZnCl2 (Figure 3.2.1 A). When excited at 515 nm, the 
solution of ZP1 (pink in color) in Tris shows very little fluorescence centered at 535 nm. As ZnCl2 
is added, it expectedly first binds the higher affinity site of ZP1 with a very small enhancement 
of fluorescence and the emission maximum stays at 535 nm as of ZP1 solution itself. Once the 
higher affinity Zn2+ binding is occupied and half-saturated ZP1-Zn forms, added Zn2+ starts 
binding to the lower affinity site with much higher increase of fluorescence and a wavelength 
shift from 535 nm to 525 nm to generate the fully saturated ZP1(Zn)2 complex. As fully 
saturated ZP1(Zn)2 forms, the color of the solution changes from pink to green. 
ZP1 + Zn2+  ZP1-Zn (535 nm, pink, weakly fluorescent) 
ZP1-Zn + Zn2+  ZP1(Zn)2 (525 nm, green, strongly fluorescent) 
The first Zn2+ binding to ZP1 with weak fluorescence and the second with strong fluorescence 
gives the titration curve a sigmoidal shape (Figure 3.2.1 B). Since the binding of Zn2+ to the 
stronger site results in very weak fluorescence, the use of ZP1 as a cellular sensor becomes 
complicated.  
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A. 
 
B. 
 
Figure 3.2.1 Titration of ZP1 with Zn2+: (A) 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated with 
increasing concentration of ZnCl2. (B) Change of fluorescence of ZP1 as it binds Zn
2+. 
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3.2.2 Reaction of LLC-PK1 cells with ZP1 
As 107 LLC-PK1 cells were incubated with 10 µM ZP1 for 15 min, very small fluorescence 
centered at 535 nm was observed that did not change over time (Figure 3.2.2 A). Since ZP1-Zn 
fluoresces with an emission maximum of 525 nm, the max of 535 nm in this reaction indicates 
either no reaction of ZP1 with the native Zn-proteome, as ZP1 solution itself shows very weak 
fluorescence at 535 nm, or some reaction other than the formation of ZP1-Zn. However, 30 µM 
TPEN, a very strong, intracellular zinc chelator, could not reverse the fluorescence that resulted 
from the reaction of LLC-PK1 cells and ZP1 (Figure 3.2.2 B), suggesting no involvement of native 
Zn2+ in the observed fluorescence. Nevertheless, it is difficult to draw any conclusion from this 
experiment, as we have seen from previous experiment (titration of ZP1 with Zn2+) that the 
intital zinc binding gives very weak fluorescence. Therefore, even if there may be some 
reactions of ZP1 with the native configuration of Zn2+, it’s unlikely to be observed and any effect 
of TPEN is also not expected. To test whether the observed fluorescence has originated due to 
the binding of extracellular Zn2+, 30 µM EDTA (ethylenediaminetetraacetic acid), a cell 
impermeable Zn2+ chelator, was introduced to the reaction of LLC-PK1 cells and ZP1. Like TPEN, 
EDTA couldn’t affect the fluorescence either ruling out the possibility of the involvement of any 
extracellular Zn2+ (Figure 3.2.2 B). 
To further investigate the source of this fluorescence, 2 x 108 LLC-PK1 cells in DPBS were 
incubated with 10 µM ZP1 for 15 min. Subsequently, the cell suspension was centrifuged and 
washed with fresh DPBS to remove any extracellular ZP1. The washed cell suspension 
resuspended in 1 mL MilliQ water was sonicated, centrifuged and the resultant cell lysate was 
fractionated using Sephadex G-75 gel filtration column. Following the elution of the fractions 
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with degassed 20 mM Tris (pH 7.4), all the collected fractions were analyzed for both 
fluorescence and zinc content. As figure 3.2.3 shows that the majority of the fluorescence 
resided in the high molecular weight fractions and nicely aligned with Zn2+ concentration in 
those fractions. The fluorescence in the high molecular weight fractions may suggest the 
formation of ternary adduct, ZP1-Zn-Protein from the reaction between Zn-Protein and ZP1.  
Zn-Protein + ZP1  ZP1-Zn-Protein 
Moreover, a small band of fluorescence in low molecular weight region also appeared, although 
no zinc was associated with this fluorescence indicating the low molecular weight fluorescence 
resulted from unbound ZP1. 
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A. 
 
 
B. 
 
 
Figure 3.2.2 Reaction of LLC-PK1 cells with ZP1. (A) 10
7 LLC-PK1 cells in DPBS were reacted with 
10 µM ZP1 for 15 min. (B) Effect of 30 µM TPEN and 30 µM EDTA on the fluorescence resulted 
from the reaction of LLC-PK1 cells and 10 µM ZP1. 
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Figure 3.2.3 Locating fluorescent species in the reaction of LLC-PK1 cells and ZP1. 2 x 10
8 LLC-
PK1 cells suspended in DPBS were incubated with 10 µM ZP1 for 15 min. The cell suspension 
was then centrifuged and resuspended in fresh DPBS, and this was repeated two more times. 
Finally the cells were resuspended in MilliQ water, sonicated, centrifuged, and the resultant cell 
lysate was loaded onto a Sephadex G-75 gel filtration column. The fractions eluted with 
degassed 20 mM Tris buffer (pH 7.4) were analyzed for fluorescence and zinc content. 
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3.2.3 Reaction of ZP1 with isolated proteome 
Isolated proteome (9 µM Zn2+) from LLC-PK1 cells was reacted with 10 µM ZP1. A significant 
increase of fluorescence compared to blank (ZP1 solution in Tris buffer) was observed and the 
emission maximum was found to be about 540 nm (Figure 3.2.4).  20 µM TPEN reduced the 
enhancement by about 44% (Figure 3.2.4B) indicating the participation of Zn2+ in the increment 
of fluorescence and the formation of ZP1-Zn-Proteome ternary adduct. 
To acquire a better insight into this reaction, the final reaction mixture following the incubation 
of isolated proteome (10 µM Zn2 ) with 10 µM ZP1 for 15 min was fractionated using a +
Sephadex G-75 gel filtration column. When the fractions eluted with 20 mM Tris (pH 7.4) were 
analyzed for fluorescence, most of the fluorescence was found in the high molecular weight 
region (Figure 3.2.5 A). This again suggested that ZP1 formed ternary adduct, ZP1-Zn-Proteome, 
with Zn-Proteome. A small low molecular weight pool of fluorescence also appeared, that might 
possibly be attributed to the unbound ZP1. As the high molecular weight fractions were reacted 
with 10 µM TPEN, the integrated fluorescence intensity was brought down by about 25% 
considering that ZP1 itself shows some fluorescence (Figure 3.2.5 B). TPEN effect further 
confirms the formation of ZP1-Zn-Proteome ternary adduct, in which TPEN may either removes 
Zn2+ from the adduct to form Zn-TPEN complex or replaces ZP1 to form TPEN-Zn-proteome. 
ZP1-Zn-Proteome + TPEN  Zn-TPEN + ZP1 + apo-Proteome 
ZP1-Zn-Proteome + TPEN  TPEN-Zn-Proteome + ZP1 
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A. 
  
B. 
 
Figure 3.2.4 Reaction of ZP1 with isolated proteome. (A) Isolated proteome containing 9 µM 
Zn2+ in 20 mM Tris buffer (pH 7.4) was reacted with 10 µM ZP1. (B) Effect of 20 µM TPEN on the 
fluorescence.  
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A. 
 
 
B. 
 
Figure 3.2.5 Sephadex G-75 gel filtration of the reaction mixture of isolated proteome (10 µM 
Zn2+) and ZP1. (A) Isolated proteome (10 µM Zn2+) in 20 mM Tris buffer (pH 7.4) was reacted 
with 10 µM ZP1. The final reaction mixture was then passed through a Sephadex G-75 gel 
filtration column and was eluted with 20 mM Tris (pH 7.4) buffer. The eluted fractions were 
analyzed for fluorescence. (B) Effect of 10 µM TPEN on the integrated fluorescence intensity of 
high molecular weight (HMW) fractions. 
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3.2.4 Titration of proteome with Zn2+ in the presence of ZP1 
As fluorescent sensors are used to image Zn2+ liberated from various cellular zinc binding sites 
or Zn2+ released from different cellular zinc stores, e.g. endoplasmic reticulum, ZP1 was probed 
to determine if it forms ternary adduct, Proteome-Zn-ZP1, with proteome and added Zn2+. In 
doing so, isolated proteome containing 9 µM Zn2+ was incubated with 10 µM ZP1 for 15 min. 
The resultant fluorescence intensity with an emission maximum of 540 nm suggested the 
formation of ternary adduct, ZP1-Zn-Protein, from the reaction of ZP1 and native Zn-Protein.  
ZP1 + Zn-Protein  ZP-Zn-Protein 
Following the incubation of proteome and ZP1 for 15 min, the final reaction mixture was 
titrated with the increasing concentration of Zn2+ (Figure 3.2.6 A and B). As Zn2+ was added, 
fluorescence intensity immediately increased. This immediate change of fluorescence indicated 
that this was not just simple titration of ZP1 with Zn2+, in which the initial strong binding gives 
little fluorescence. Thus, the fluorescence increase in this titration is not due to the formation 
of ZP1-Zn complex. Moreover, as the fluorescence intensity further increased with the addition 
of more zinc, the emission maximum stayed unchanged at 535-540 nm. This differs from the 
titration of ZP1 with Zn2+, where initially the emission maximum is 540 nm at low concentration 
of Zn2+ and low fluorescence intensity, but shifts to 525 nm as the concentration of Zn2+ 
increases with higher fluorescence intensity. All these differences from the titration of ZP1 and 
Zn2+ suggested the formation of ProteomeZn-ZP1 ternary adduct, where the added Zn2+ binds 
various adventitious zinc binding sites of proteome which in turn binds ZP1. 
Proteome + ZP1 + Zn2+  Proteome.Zn-ZP1 
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To confirm the notion of ProteomeZn-ZP1 ternary adduction generation, the final reaction 
mixture following the titration of proteome with Zn2+ in the presence of ZP1 was fractionated 
using a Sephadex G-75 gel filtration column. As the fractions eluted with 20 mM Tris buffer (pH 
7.4) were analyzed for both fluorescence and zinc content, most of the fluorescence was found 
associated with the high molecular weight fractions (Figure 3.2.6 C). The emission maximum of 
the fluorescence spectrum in these fractions was found to be 535 nm. Moreover, the 
fluorescence intensities in high molecular weight fractions were very consistent with the zinc 
concentrations in those fractions (Figure 3.2.7 A). The residence of the majority of the 
fluorescence in the high molecular weight fractions further points to the formation of 
ProteomeZn-ZP1 ternary adduct. However, a small low molecular weight fluorescence pool 
also emerged. The absence of measurable zinc in those low molecular weight fractions 
indicated that the unbound ZP1 might be attributed to this small pool of fluorescence. The 
effect of 10 µM TPEN on the fluorescence intensities of the high molecular weight fractions 
further validates the claim of the generation of ternary adduct, ProteomeZn-ZP1 in this 
reaction. TPEN quenched the integrated fluorescence intensity of the high molecular weight 
proteomic fractions almost by 50% (Figure 3.2.7 B). 
ProteomeZn-ZP1 + TPEN  Proteome + Zn-TPEN + ZP1 
ProteomeZn-ZP1 + TPEN  ProteomeZn-TPEN + ZP1 
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A. 
 
B.   
 
Figure 3.2.6 Titration of proteome with Zn2+ in the presence of ZP1. (A) Proteome containing 9 
µM Zn2+ was reacted with the increasing concentration of Zn2+. (B) Change of fluorescence with 
the increasing concentration of Zn2+. 
 74 
 
A. 
 
B. 
 
Figure 3.2.7 Sephadex gel filtration of the proteome titrated with ZnCl2 in the presence of ZP1. 
(A) Proteome (9 µM Zn2+) was reacted with the increasing concentration of Zn2+.The final 
reaction mixture was fractionated using a Sephadex G-75 gel filtration column and the fractions 
eluted with 20 mM Tris (pH 7.4) were analyzed for both fluorescence and zinc content. (B) 
Effect of 10 µM TPEN on the integrated fluorescence intensity of high molecular weight 
fractions.  
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3.2.5 Reaction of proteome with Zn-ZP1 
The formation of ternary adduct ProteomeZn-ZP1 following the reaction of isolated proteome 
with ZP1 and added Zn2+ was investigated another way. Isolated proteome containing 9 µM Zn2+ 
was reacted with pre-mixed ZP1(Zn)2. As 20 µM ZP1(Zn)2 (emission maximum of 525 nm) was 
added to proteome, the emission maximum shifted to 540 nm indicating the production of 
ProteomeZn-ZP1 ternary adduct species (Figure 3.2.8 A).  
Proteome + ZP(Zn)2  ProteomeZn-ZP1 
To confirm the generation of ProteomeZn-ZP1 ternary adduction species, the final reaction 
mixture was fractionated using a Sephadex G-75 gel filtration column. As the fractions eluted 
with 20 mM Tris buffer (pH 7.4) were analyzed for both fluorescence and zinc content, most of 
the fluorescence (63%) was found associated with the high molecular weight fractions (Figure 
3.2.8 B). The emission maximum of the fluorescence spectrum in these fractions was found to 
be 535 nm. Moreover, the fluorescence intensities in high molecular weight fractions were very 
consistent with the zinc concentrations in those fractions. The residence of the majority of the 
fluorescence in the high molecular weight fractions further points to the formation of 
ProteomeZn-ZP1 ternary adduct. However, a small low molecular weight fluorescence pool 
also emerged. The absence of measurable zinc in those low molecular weight fractions 
indicated that the unbound ZP1 might generate this small pool of fluorescence. The effect of 10 
µM TPEN on the fluorescence intensities of the high molecular weight fractions further 
validated the claim of the generation of ternary adduct, ProteomeZn-ZP1 in this reaction. 
 76 
 
TPEN quenched the integrated fluorescence intensity of the high molecular weight proteomic 
fractions almost by 82% (Figure 3.2.8 C). 
A. 
 
 
B. 
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C. 
 
 
Figure 3.2.8 Reaction of proteome with ZP1(Zn)2. (A) Reaction of proteome (9 µM Zn
2+) with 10 
µM and 20 µM ZP1(Zn)2. (B) The final reaction mixture was loaded onto a Sephadex G-75 gel 
filtration column and the fractions were eluted with 20 mM Tris buffer (pH 7.4). Both 
fluorescence and zinc content were determined for each of the eluted fractions. (C) Effect of 20 
µM TPEN on the integrated fluorescence intensity of the high molecular weight fractions. 
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3.2.6 Reaction of ZP1 with TSQ-Zn-Proteome 
As TSQ reacts with Zn-proteome and forms ternary adduct TSQ-Zn-Proteome, ZP1’s ability to 
replace TSQ from this ternary adduct and, thus, to form new ternary adduct species ZP1-Zn-
Proteome was probed. In doing so, isolated proteome containing 12 µM Zn2+ was first reacted 
with 20 µM TSQ for an hour. As expected, a gradual increase of fluorescence with an emission 
maximum of 470 nm – signature of the generation of TSQ-Zn-Proteome ternary adduct species 
– was observed. Afterwards, the reaction mixture was titrated with the increasing 
concentration of ZP1, the fluorescence intensity at 470 nm rapidly quenched and at the same 
time, a fluorescence peak at 535 nm, which gradually shifted to 540 nm at higher concentration 
of ZP1, appeared (Figure 3.2.8 A). The loss of fluorescence intensity at 470 nm and the 
emergence of fluorescence at 535-540 nm suggest the replacement of TSQ from the ternary 
adduct TSQ-Zn-Proteome (470 nm) and as such the creation of the new ternary adduct ZP1-Zn-
Proteome (540 nm). 
Zn-Proteome + TSQ  TSQ-Zn-Proteome 
TSQ-Zn-Proteome + ZP1  ZP1-Zn-Proteome + TSQ 
We also considered the possibility that the reduction of fluorescence intensity at 470 nm 
following the introduction of ZP1 might be attributed to the inner filter effect, i.e. ZP1 remains 
unreactive with TSQ-Zn-Proteome and instead, absorbs the emitted light at 470 nm and thus 
quenches the fluorescence. Despite the fact that the non-linear loss of fluorescence at 470 nm 
with the increasing concentration of ZP1 ruled out the possibility of inner filter effect (Figure 
3.2.9 B), for further confirmation we fractionated the final reaction mixture using a Sephadex 
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G-75 gel filtration column and compared the fluorescence intensities of the high molecular 
weight fractions with those of a control experiment, in which isolated proteome containing 12 
µM Zn2+ was reacted with 20 µM TSQ followed by the fractionation of the final reaction 
mixture. In the case of the ZP1 treated reaction, the fluorescence intensity at 470 nm of the 
high molecular weight fractions was much lower (Figure 3.2.10 B) compared with that of the 
control experiment (Figure 3.2.10 A). If the reduction of fluorescence at 470 nm were due to 
the inner filter effect of ZP1, the fluorescence intensities of high molecular weight fractions 
should have returned following gel filtration. In fact, the integrated fluorescence intensities at 
470 nm of high molecular weight fractions turned out to be only 39% of those of the control 
experiment (Figure 3.2.11 A). All these findings cancel the possibility that the inner filter effect 
of ZP1 played any role in reducing the fluorescence of TSQ-Zn-Proteome ternary adduct at 470 
nm. Furthermore, the quenching of the integrated fluorescence intensity of 540 nm of the high 
molecular weight fractions by 40-50% by 20 µM TPEN further confirms the formation of a ZP1-
Zn-Proteome ternary adduct that replaces TSQ from TSQ-Zn-Proteome (Figure 3.2.11 B). 
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A. 
 
 
B. 
 
 
Figure 3.2.9 Reaction of ZP1 and proteome incubated with TSQ. (A) Proteome (12 µM Zn2+) 
was reacted with 20 µM TSQ for an hour. Following on, the reaction mixture was titrated with 
ZP1. (B) Change of fluorescence at 470 nm, 540 nm, control 540 nm and ZP1 absorbance with 
the increasing concentration of ZP1. 
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A. 
 
 
B. 
 
 
Figure 3.2.10 Sephadex gel filtration of proteome reacted with TSQ and ZP1. (A) Control: The 
final reaction mixture of proteome and 20 µM TSQ was fractionated using a Sephadex G-75 gel 
filtration column and the high molecular weight fractions eluted with 20 mM Tris buffer (pH 
7.4) were analyzed for fluorescence. (B) Fluorescence spectrum of the high molecular weight 
fractions collected by fractionation of the final reaction mixture of proteome, TSQ and ZP1. 
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C. 
 
 
D. 
 
Figure 3.2.11 Integrated fluorescence of high molecular weight (HMW) fractions and TPEN 
effect. (A) Comparison of the integrated fluorescence intensities of the high molecular weight 
fractions between control and ZP1 treated reactions. (B) The effect of 20 µM TPEN on the 
integrated fluorescence intensity of the high molecular weight fractions of ZP1 treated reaction. 
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3.2.7. Reaction of ZP1 with model zinc proteins, such as alcohol dehydrogenase 
ZP1 formed ternary adduct ZP-Zn-Proteome with native Zn-Proteome and Proteom.Zn-ZP1 with 
proteome and added Zn2+. Next we wanted to investigate if ZP1 forms ternary adduct with 
different model Zn-proteins, such as alcohol dehydrogenase. Each alcohol dehydrogenase 
monomer unit has one catalytic zinc and one structural zinc.90  
As 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated with the increasing concentration of alcohol 
dehydrogenase (ADH), a small but gradual enhancement of fluorescence was observed (Figure 
3.2.12 A). The emission maximum of the fluorescence spectrum stayed at 536 nm. These 
observations suggested the generation of ternary adduct ZP1-Zn-ADH between ZP1 and alcohol 
dehydrogenase (Zn-ADH). However, even after the addition of alcohol dehydrogenase that 
contained 60 µM Zn2+, the fluorescence intensity was still gradually increasing indicating weak 
interaction between ZP1 and alcohol dehydrogenase. As the final reaction mixture was reacted 
with 20 µM TPEN, the fluorescence intensity was almost completely reversed to the blank (ZP1 
in Tris) (Figure 3.2.12 B). The TPEN effect further suggests the formation of ternary adduct 
species, ZP1-Zn-ADH and its reaction with TPEN as follows: 
ZP1 + Zn-ADH  ZP1-Zn-ADH 
ZP1-Zn-ADH + TPEN  Zn-TPEN + ZP1 + ADH 
ZP1-Zn-ADH + TPEN  TPEN-Zn-ADH + ZP1 
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To further confirm the formation of ternary adduct ZP1-Zn-ADH, the final reaction mixture of 10 
µM ZP1 and alcohol dehydrogenase containing 60 µM Zn2+ was fractionated using a Sephadex 
G-75 gel filtration column and the fractions were eluted with 20 mM Tris buffer (pH 7.4). As the 
fractions were analyzed, the majority of the fluorescence was found in the low molecular 
weight region (Figure 3.2.12 C). This might be due to the weak binding of ZP1 and Zn-ADH in 
forming ZP1-Zn-ADH ternary adduct that was implied in the earlier experiment described by 
Figure 3.2.9 A and its subsequent dissociation during gel filtration. 
ZP1-Zn-ADH  ZP1 + Zn-ADH 
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B. 
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C. 
 
Figure 3.2.12 Reaction of ZP1 with alcohol dehydrogenase. (A) 10 µM ZP1 in 20 mM Tris (pH 
7.4) was reacted with increasing concentration of alcohol dehydrogenase. (B) The effect of 20 
µM TPEN on the reaction between 10 µM ZP1 and alcohol dehydrogenase containing 60 µM 
Zn2+. (C) Fractionation of the final reaction mixture of 10 µM ZP1 and alcohol dehydrogenase 
containing 60 µM Zn2+ and the measurement of fluorescence of the fractions. 
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3.3 Reaction of Zn-proteome with Diethylamine NONOate (DEA-NO) in the 
presence of Zinquin/TSQ/FluoZin-3 
The in vitro titration of proteome with Zn2+ in the presence of Newport Green (NPG) or Zinpyr-1 
(ZP1) – a model of intracellular reaction of the sensor with the mobile Zn2+ in the presence of 
proteomic zinc binding ligands – has displayed two different results with two sensor with 
dissimilar stability constants. NPG, because of its low stability constant (10-5 – 10-6 M), could not 
compete with the proteome and form Zn-NPG (reaction 3.3.1), while the higher affinity sensor 
ZP1 (0.7 nM) generated ProteomeZn-ZP1 ternary adduct (reaction 3.3.2). Neither could form 
Zn-Sensor complex. 
Proteome + Zn2+ + NPG ⇌ ProteomeZn + NPG      (3.3.1) 
Proteome + Zn2+ + ZP1 ⇌ ProteomeZn-ZP1          (3.3.2) 
These findings clearly show that the ability of the zinc senor to image intracellular mobile Zn2+ 
depend on its relative binding affinity compared to that of the proteomic ligands. To rationalize 
this finding in terms of an actual cellular process that triggers the release of Zn2+, LLC-PK1 cells 
were reacted with nitric oxide (NO), which reacts with the proteomic sulfhydryl groups that 
coordinate Zn2+ in specific proteins and thus causes the liberation of Zn2+.86 The sensor’s ability 
of imaging this mobile released Zn2+ was studied using three different fluorescent zinc sensors – 
Zinquin (ZQ), TSQ and FluoZin-3.  
Nitric oxide (NO) acts as a regulatory molecule, which induces the release of Zn2+ following its 
reaction with sulfhydryl groups.91-94 However, the nitrosation of the sulfhydryl groups by nitric 
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oxide is not straightforward. The following reactions describe the various ways the thiol groups 
are nitrosated by reactive nitrogen oxide species.95 
2 ·NO + O2  2 
·NO2 
2 ·NO + 2 ·NO2  2 N2O3 
N2O3 + RSH  RSNO + NO2
- + H+ 
 
RSH + ·NO2  RS
· + NO2
- + H+ 
RS· + ·NO  RSNO 
 
The sulfhydryl groups can be oxidized as well following the reaction with nitric oxide.95 
RS· + ·SR  RSSR 
RS· + O2  RSOO
· 
RS· + RS-  RSSR·- 
RSSR·- + O2  RSSR + O2
·- 
 
Previous studies have reported that the primary target of NO is Zn7-metallothionein (Zn7-MT), 
which binds 7 Zn2+ ions in two thiolate clusters.54, 56, 96-98 For example, Pitt et al. hypothesized 
that nitric oxide exposed to or synthesized within lung endothelial cells reacts with thiolate 
groups of Zn7-MT and releases Zn
2+.54 The liberation of Zn2+ was supported from the 
fluorescence enhancement of the sensors ZQ and FluoZin-3. However, other studies have found 
that NO is not particularly reactive with Zn7-MT.
15 Therefore, questions arise as to the source of 
Zn2+ imaged by these sensors and the identity of the fluorescent species that causes the 
enhancement of fluorescence. An alternative possible source of Zn2+ released following NO 
exposure is proteomic Zn2+, which is then sensed by ZQ and FluoZin-3 in the above mentioned 
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study. However, as ZQ and TSQ image Zn-proteins through the formation of ZQ/TSQ-Zn-Protein 
ternary adduct, they may also generate ProteomeZn-ZQ/TSQ with Zn2+ adventitiously bound 
to proteome upon release. 
Zn-S-Proteome + NO ⇌ NO-S-Proteome + Zn2+ 
Proteome + Zn2+ + ZQ/TSQ ⇌ ProteomeZn-ZQ/TSQ 
These present experiments were undertaken to better understand the underlying chemistry of 
the reaction of proteome with nitric oxide (NO) monitored by the fluorescent zinc sensor 
Zinquin, TSQ and FluoZin-3. 
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3.3.1. Reactions of the LLC-PK1 cells with DEA-NO in the absence or presence of Zinquin (ZQ).   
Pig kidney LLC-PK1 cells were used to investigate the impact of nitric oxide on the availability of 
intracellular Zn2+ to react with fluorescent zinc sensors.  DEA-NO, which releases NO with a half 
time of about 20 min, served as the source of nitric oxide.86  Initially, 1x107 LLC-PK1 cells were 
incubated with 20 µM Zinquin ethyl ester (ZQee) for 30 min.  During this time the charge neutral 
probe diffused into the cells and began to undergo ester hydrolysis.  A fluorescence emission 
spectrum centered at 470 nm was observed, indicative of the formation of a ternary adduct 
species, ZQ-Zn-Proteome (Figure 3.3.1 A).50 Based on previous estimates, the amount of 
protein-bound zinc participating in adduct formation represents about 10-15% of the total.50 
The introduction of 500 µM DEA-NO to the cells for another 25 min reduced the sulfhydryl 
concentration from 78 µM to 44 µM and caused a gradual increase of fluorescence at 470 nm, 
along with a noticeable shoulder at 490 nm (Figure 3.3.1 A).  Moreover, the fluorescence ratio 
at 490 nm to 470 nm increased along the course of the reaction (Figure 3.3.1 B). Compared 
with the reaction of cells with ZQee, a 25% increment in fluorescence intensity was observed 
(Figure 3.3.1 C) – consistent with the study by Pitt et al.54  Subsequently, 10 µM TPEN, a cell 
permeable, strong zinc chelator, reversed the fluorescence to 17% of the baseline of cell 
background fluorescence (Figure 3.3.1 C), confirming that both enhancement of fluorescence 
followed by the treatment of ZQee and then DEA-NO involved the participation of Zn
2+.  
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B. 
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C. 
 
Figure 3.3.1 Reaction of LLC-PK1 cells with DEA-NO in the presence of Zinquin ethyl ester: (A) 
Fluorescence spectra of the reaction between 107 LLC-PK1 cells and 20 µM Zinquin ethyl ester 
(ZQee) for 30 min followed by the treatment with 500 µM DEA-NO for another 25 min. (B) The 
change of fluorescence ratio at 490 nm to 470 nm with time. (C) Percent enhancement of 
fluorescence upon addition of 500 µM DEA-NO and its reversal by 10 µM TPEN. 
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The appearance of the shoulder at 490 nm suggested the mobilization of Zn2+ by NO released 
spontaneously from DEA-NO and, in turn, the production of the Zn(ZQ)2 complex (Reaction 1), 
which fluoresces with an emission maximum of 490 nm.1-3 Another contributor to the 
fluorescence increase at 470 nm might be Zn2+ mobilized from Zn-proteins that non-specifically 
rebound to other adventitious binding sites.  In turn, Zn●Proteome may bind ZQ to generate 
Zn-ZQ●Proteome species that fluoresce at 470 nm.  
Zn-S-Protein + NO + 2 ZQ ⇌ NO-S-Protein + Zn(ZQ)2      (1) 
To investigate further the basis for the above observations, 1.25 x 108 LLC-PK1 cells were 
incubated with 20 µM ZQee for 30 min at room temperature before the subsequent addition of 
500 µM DEA-NO for another 40 min.  The cells were then lysed, centrifuged and the resultant 
supernatant separated by gel filtration using a Sephadex G-75 column.  As the fractions were 
analyzed for both fluorescence and zinc content, high molecular weight (HMW) and low 
molecular weight (LMW) pools for both fluorescence and zinc were found for both control 
(reaction of cells and ZQee) and DEA-NO treated (reaction of cells and ZQee followed by DEA-
NO) cells (Figure 3.3.2A & B). In addition, proteome associated fluorescence increased by 16% 
in DEA-NO treated cells compared to control.  The low molecular weight fluorescence pool of 
control reaction constituted 19% of the total fluorescence (high molecular weight and low 
molecular weight), whereas that of DEA-NO treated reaction represented 32% (Figure 3.3.2C). 
The spectra of low molecular weight fractions centered around 490 nm.  Consistent with the 
fluorescence data, the low molecular weight zinc content after DEA-NO treatment was 
calculated to be 13% of the total zinc, whereas that of control reaction was only 5 % (Figure 
3.3.2C).  The significant increase of both the low molecular weight zinc content and its 
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accompanying fluorescence emission centered at 490 nm indicated the formation of Zn(ZQ)2  
during the reaction of NO with cells.  ZQ may have reacted with Zn2+ associated with or released 
from native Zn2+ binding sites that had been modified and weakened by nitric oxide.  
Alternatively, Zn2+ at such sites may have shifted to non-specific sites of binding within the 
proteome and reacted with ZQ to generate Zn(ZQ)2 (reactions 2 and 3): 
Zn-NOS-Proteins + Proteome ⇋ NO-S-Proteins + Zn●Proteome    (2) 
2 ZQ + Zn●Proteome ⇌ Zn(ZQ)2 + Proteome    (3) 
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Figure 3.3.2 Sephadex G-75 filtration of LLC-PK1 cells incubated with 20 µM Zinquin ethyl ester 
(ZQee) followed by 500 µM DEA-NO. (A) 108 LLC-PK1 cells were reacted with 500 µM DEA-NO 
for 40 min following 20 µM ZQee for 30 min. The cells were lysed, centrifuged, and the 
supernatant was separated using a Sephadex G-75 column. The fractions were analyzed for 
both fluorescence and zinc. (B) Control: a parallel reaction was run at identical condition with 
no DEA-NO added. (C) Comparison of the low molecular weight (LMW) fluorescence and zinc 
content between control and DEA-NO exposed cells. 
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3.3.2. Reaction of isolated proteome with DEA-NO in the presence of Zinquin acid (ZQacid).  
To verify the interpretation of the reaction of NO and ZQ with LLC-PK1 cells, isolated proteome 
(10 µM Zn2+) was first reacted with 20 µM ZQacid for 45 min at room temperature. As in whole 
cells, a gradual increase of fluorescence with the emission maximum of 470 nm was observed, 
indicative of the formation of ZQ-Zn-Protein ternary adduct.  Subsequently, 500 µM DEA-NO 
was added for an hour. When the final reaction mixture was separated using a Sephadex G-75 
column, a noticeable low molecular weight pool of fluorescence and zinc – larger than that of 
control – was seen (Figure 3.3.3 A & B). The LMW fluorescence pool (emission maximum of 490 
nm) was measured to be 50% of total fluorescence, which is 40% greater than that of control 
(30% of total fluorescence) and displayed an emission maximum at 490 nm (Figure 3.3.3C). 
Consistently, the LMW zinc pool was found to three times greater than that of control 
proteome (15% of total zinc content vs. 5%). The reduction of sulfhydryl content by 41% (from 
212 µM to 126 µM) following the treatment with DEA-NO (Figure 3.3.3D) supported the 
reaction between proteomic sulfhydryl groups and nitric oxide. As in whole cells, the low 
molecular weight fluorescence and zinc pool in the reaction of isolated proteome indicated the 
production of Zn(ZQ)2. Moreover, proteome fluorescence intensity increased by 19% of the 
control suggesting the generation of new ternary adduct sites resulted from the labilization of 
Zn2+. 
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Figure 3.3.3 Sephadex G-75 filtration of isolated proteome incubated with 20 µM Zinquin acid 
(ZQacid) followed by 500 µM DEA-NO. (A) Isolated proteome (10 µM Zn2+) was reacted with 20 
µM ZQacid for 45 min followed by 500 µM DEA-NO for another 1 hour. The final reaction 
mixture was separated using a Sephadex G-75 column, and the fractions were analyzed for both 
fluorescence and zinc content. (B) Control: a parallel reaction was run at identical condition 
with no DEA-NO added. (C) Comparison of the low molecular weight (LMW) fluorescence and 
zinc content. 
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3.3.3. Reaction of the whole LLC-PK1 cells with DEA-NO in the presence of TSQ. 
Like Zinquin, TSQ also reacted with LLC-PK1 cells to form TSQ-Zn-Proteome ternary adducts, as 
was evident from the fluorescence spectrum centered at around 470 nm. Incubation with 500 
µM DEA-NO for 40 min caused a two-fold increase of fluorescence with the emission maximum 
shifted at 480 nm (Figure 3.3.4 A), substantially more than obtained with Zinquin.  However, 
the change of fluorescence ratio at 490 nm to 470 nm was not as prominent as in the case of 
Zinquin (Figure 3.3.4 B). As with ZQ, 10 µM TPEN was able to reduce the fluorescence to 32% of 
the control value (100%), indicating the participation of Zn2+ in the enhancement of 
fluorescence followed by the addition of both TSQ and DEA-NO as well as the ability of TPEN to 
reverse much of the control fluorescence enhancement by TSQ (Figure 3.3.4 C). Consistent with 
the fluorescence enhancement, the sulfhydryl concentration reduced from 74 µM to 45 µM. 
To characterize the fluorescent species, LLC-PK1 cells were incubated with 20 µM TSQ for 40 
min followed by 500 µM DEA-NO for another 45 min. Cells were then washed, lysed and 
centrifuged, and the resultant supernatant was fractionated using Sephadex G-75 column. 
Contrary to the case of Zinquin, no detectable pool of low molecular weight fluorescence and 
zinc as Zn(TSQ)2 was found in either DEA-NO treated or control cells (Figure 3.3.5 A & B). 
Almost all the fluorescence and zinc was found in the high molecular weight proteome 
fractions. The integrated fluorescence intensity of the high molecular weight fractions was 50% 
greater than that of control (Figure 5C) and was aligned with the Zn2+ concentrations in the 
fractions. Moreover, the emission maxima of the proteomic fractions were found to be about 
470 nm, indicative of TSQ-Zn-Proteome species.  In contrast to the results with ZQ, these 
findings indicate that Zn2+ mobilized by incubation with DEA-NO remains bound completely 
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within the proteome in the presence of TSQ, forming ternary adducts instead of Zn(TSQ)2.  
Possibly, such adducts involve Zn2+ previously unavailable for reaction with TSQ that is still 
associated with its original binding sites even after modification by NO (reaction 4).  
Alternatively, Zn2+ at such sites might be redistributed to non-specific binding sites that 
secondarily react with TSQ.  Apparently, due to its lower affinity for Zn2+ relative to ZQ, TSQ 
cannot compete with these newly formed  adducts to generate Zn(TSQ)2 species. 
Zn-S-Proteins + NO ⇌ Zn-NO-S-Proteins        (4) 
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Figure 3.3.4 Reaction of LLC-PK1 cells with DEA-NO in the presence of TSQ. (A) Fluorescence 
spectra of the reaction between 107 LLC-PK1 cells and 20 µM TSQ for 30 min followed by the 
treatment with 500 µM DEA-NO for another 25 min. (B) The change of fluorescence ratio at 490 
nm to 470 nm with time. (C) Percent enhancement of fluorescence upon addition of 500 µM 
DEA-NO and its reversal by 10 µM TPEN. 
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Figure 3.3.5 Sephadex G-75 filtration of LLC-PK1 cells incubated with TSQ followed by 500 µM 
DEA-NO. (A) 108 LLC-PK1 cells were reacted with 500 µM DEA-NO for 45 min following 20 µM 
TSQ for 40 min. The cells were lysed, centrifuged, and the supernatant was separated using a 
Sephadex G-75 column. The fractions were analyzed for both fluorescence and zinc. (B) Control: 
a parallel reaction was run at identical condition with no DEA-NO added. (C) Comparison of the 
integrated fluorescence intensity of proteome. 
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3.3.4. Reaction of isolated proteome with DEA-NO in the presence of TSQ.  
The reaction of DEA-NO and TSQ with LLC-PK1 cells was examined in a simpler system.  Isolated 
proteome containing 10 µM Zn2+ was reacted with 20 µM TSQ for 40 min before 500 µM DEA-
NO was added for another one hour.  The reduction of sulfhydryl concentration by 41% (from 
340 µM to 200 µM) indicated a significant extent of reaction between nitric oxide and 
proteomic sulfhydryl groups (Figure 3.3.6).  Upon fractionation using gel filtration, as was 
observed in the reaction of whole cells, no measurable low molecular weight fluorescence or 
zinc was found.  That is, no Zn(TSQ)2 was formed in either DEA-NO treated and control 
reactions. 
 
Figure 3.3.6 Reaction of isolated proteome with DEA-NO in the presence of TSQ. Isolated 
proteome (10 µM Zn2+) was reacted with 20 µM TSQ for 40 min followed by 500 µM DEA-NO 
for another 1 hour.  The final reaction mixture was separated using a Sephadex G-75 column, 
and the fractions were analyzed for both fluorescence and zinc content. 
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3.3.5. Reaction of isolated proteome with added Zn2+ in the presence of excess TSQ/ZQ.   
The capacity of the proteome to bind adventitious Zn2+ in the absence or presence of DEA-NO 
and TSQ or ZQ was also investigated in order to probe the involvement of reactions 3 and 4 in 
the previously observed reactions of Zn-proteins with DEA-NO and these sensors.  Control 
isolated proteome (8 µM Zn2+) was titrated with Zn2+ in the presence of excess ZQ or TSQ.  The 
fluorescence emission intensity centered at about 470 nm, due to the formation of ZQ/TSQ-
Zn●Proteome ternary adducts, increased in parallel with the concentration of added Zn2+  
(Figures 3.3.7 A & 3.3.8 A).  However, in both cases, the emission maximum remained 
unchanged at 470 nm as Zn2+ was added to the proteome. Moreover, when the final reaction 
mixtures were fractionated by Sephadex gel filtration, no measurable low molecular weight 
fluorescence or zinc was detected with either fluorophore (Figures 3.3.7 B & 3.3.8 B).  Thus, the 
proteome contained extensive capacity to bind Zn2+ and form adducts with Zn2+ and either 
sensor (reactions 5, 6).   
Zn-Proteome + *Zn2+  ⇋  Zn-Proteome●*Zn      (5) 
Zn-Proteome●*Zn  + 2TSQ/ZQ  ⇋  TSQ/ZQ-Zn-Proteome●Zn-TSQ/ZQ     (6) 
Although consistent with the previous observations with TSQ in the absence or presence of 
DEA-NO, these results differ from the findings about the reaction of cells or proteome with 
DEA-NO in the presence of Zinquin.  In that case, a red shifted emission maximum and a 
detectable low molecular weight fluorescence and zinc pool indicated that some Zn(ZQ)2 are 
produced. 
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The variance in outcome related to the absence or presence of DEA-NO suggested that the 
behavior of ZQ depends on the existence and extent of modification of sulfhydryl groups that 
participate in the adventitious proteomic binding of Zn2+ (*Zn2+) (reactions 7, 8) .    
Zn-S-Proteome-SH + *Zn2+   ⇋  Zn-S-Proteome-S-*Zn2+      (7) 
[RS- + ·NO  RS· + NO- 
RS· + ·NO  RSNO] 
Zn-S-Proteome-S-*Zn2+  +  2 NO ⇋   NO-S-Proteome-S-NO  + 2 Zn2+  (8) 
As the number of adventitious binding sites for Zn2+ is reduced through reaction with NO, the 
formation of Zn(ZQ)2 becomes more favorable.  However, with TSQ, its lower affinity for Zn
2+ 
prevents competitive generation of Zn(TSQ)2 even in the face of reduced numbers of proteomic 
binding sites for Zn2+. According to this hypothesis, DEA-NO reduced the number of 
adventitious binding sites by modifying important sulfhydryl groups. As a result, some, if not all, 
of the labile Zn2+ can be sequestered as Zn(ZQ)2 (reaction 9). 
NO-S-Proteome-S-NO + 2 Zn2+ + 4 ZQ  ⇋  NO-S-Proteome-S-NO  + 2 Zn(ZQ)2 (9) 
 
 
 
 
 
 109 
 
A. 
 
 
B. 
 
 
 
 110 
 
C. 
 
Figure 3.3.7 Titration of isolated proteome with ZnCl2 in the presence of Zinquin acid. (A) 
Isolated proteome (8 µM Zn2+) was reacted with 20 µM Zinquin acid for 30 min (the 
bottommost spectrum). Following on, the reaction mixture was titrated with the increasing 
concentration of ZnCl2. (B) The change of fluorescence ratio at 490 nm to 470 nm. (C) The final 
reaction mixture from (A) was fractionated using Sephadex gel filtration, and the eluted 
fractions were analyzed for both fluorescence and zinc content. 
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Figure 3.3.8 Titration of isolated proteome with ZnCl2 in the presence TSQ.  (A) Isolated 
proteome (8 µM Zn2+) was reacted with 20 µM TSQ for 30 min (the bottommost spectrum). 
Following on, the reaction mixture was titrated with the increasing concentration of ZnCl2. (B) 
The change of fluorescence ratio at 490 nm to 470 nm. (C) The final reaction mixture from (A) 
was fractionated using Sephadex gel filtration, and the eluted fractions were analyzed for both 
fluorescence and zinc content. 
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3.3.6. Reaction of isolated proteome with DEA-NO in the presence of FluoZin-3.   
The reaction of isolated proteome (10µM Zn2+) with 500 µM DEA-NO was also monitored using 
another Zn2+ sensor that does not form ternary complexes with Zn-proteins, FluoZin-3 (20 µM). 
The absence of any fluorescence signal during the reaction of proteome and FluoZin-3 for 20 
min indicated that Zn-proteome did not react with FluoZin-3 to form any ternary adduct.  
However, the introduction of DEA-NO to the reaction mixture for 1 hour caused a gradual 
increase of fluorescence throughout this period (Figure 3.3.9).  Interestingly, addition of 10 µM 
TPEN, a powerful Zn2+ chelator, at an intermediate time did not quench any of the enhanced 
fluorescence. Instead, the fluorescence signal continued increasing. This datum suggested that 
the increase of fluorescence was not due to the formation of Zn-FluoZin-3 complex, because its 
fluorescence should have been reversed upon the addition of TPEN. The proteomic sulfhydryl 
concentration was reduced by 41% (from 342 µM to 202 µM) after the reaction of proteome 
with DEA-NO. In a separate experiment, upon fractionation of the final reaction mixture of 
proteome (10 µM Zn2+), 20 µM FluoZin-3 and 500 µM DEA-NO using a Sephadex G-75 column, 
no Zn-FluoZin-3 complex was found (Figure 3.3.10) meaning FluoZin-3 does not chelate 
proteomic Zn2+. 
To investigate the source of this fluorescence enhancement, 20 µM FluoZin-3 was reacted with 
500 µM DEA-NO for 1 hour followed by 10 µM TPEN for another 10 min.  A gradual increase of 
fluorescence even larger than in the proteome experiment was observed.  Again, 10 µM TPEN 
could not reverse the intensification of the fluorescence.  It was concluded that NO reacts with 
FluoZin-3 with an increase of fluorescence, independent of its reaction with Zn2+. This finding is 
of particular importance, because the reaction of NO and FluoZin-3 may confuse the 
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researchers studying the induction of zinc release by nitric oxide in the presence of FluoZin-3, 
unless not confirmed by TPEN. 
 
 
3.3.7. Reaction of isolated proteome with DEA-NO prior to FluoZin-3.  
Isolated proteome containing 5 µM Zn2+ was incubated with 500 µM DEA-NO for an hour and 
subsequently, 20 µM FluoZin-3 was added for another 30 min. Fluorescence slowly increased 
with time and 10 µM TPEN did not reverse the fluorescence (Figure 3.3.11 A). This again 
suggests that the fluorescence enhancement is due not to the reaction of FluoZin-3 with 
proteomic Zn2+, rather to that of FluoZin-3 and nitric oxide. 
When the final reaction mixture of another experiment – reaction of isolated proteome (5 µM 
Zn2+) pre-incubated with 500 µM DEA-NO for an hour followed by 20 µM FluoZin-3 – was 
fractionated using Sephadex G-75 column, neither high molecular weight fluorescence nor low 
molecular weight Zn-FluoZin3 was obtained (Figure 3.3.11 B).  
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Figure 3.3.9 Reaction of isolated proteome with DEA-NO in the presence of FluoZin-3.   
Isolated proteome (10 µM Zn2+) was reacted with 20 µM FluoZin-3 for 20 min followed by 500 
µM DEA-NO for another hour. Finally 10 µM TPEN was added for 10 min. As control 
experiment, 20 µM FluoZin-3 in 20 mM Tris (pH 7.4) was reacted with 500 µM DEA-NO for an 
hour followed by 10 µM TPEN for another 10 min. The arrow indicates the time of TPEN 
addition. 
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Figure 3.3.10 Sephadex gel filtration of proteome incubated with DEA-NO in the presence of 
FluoZin-3. Proteome (10 µM Zn2+) was reacted with 20 µM FluoZin-3 for 20 min. Subsequently, 
500 µM DEA-NO was introduced into the reaction mixture for an hour. Following on, the final 
reaction mixture was fractionated using Sephadex G-75 gel filtration chromatography. The 
fractions eluted with 20 mM degassed Tris buffer at pH 7.4 were analyzed for fluorescence and 
zinc content. 
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Figure 3.3.11 Reaction of isolated proteome (5 µM Zn2+) with 500 µM DEA-NO followed by 20 
µM FluoZin-3. (A) Proteome was incubated with 500 µM DEA-NO for one hour before 20 µM 
FluoZin-3 was introduced for another 30 min. At this time point, 10 µM TPEN was added for an 
additional 15 min. (B) Sephadex G-75 fractionation of the final reaction mixture of isolated 
proteome pre-incubated with 500 µM for an hour followed by 20 µM FluoZin-3.  
 
 118 
 
3.3.8 Stability of Zn-FluoZin3 in the presence of proteome 
The ability of FluoZin-3 to sense mobilized Zn2+ in the context of proteomic environment was 
investigated by titrating isolated proteome (12 µM Zn2+) with added Zn2+ in the presence of 10 
µM FluoZin-3. Unexpectedly, no significant change in fluorescence was observed until about 10-
12 µM Zn2+ was added (region I), whereas a simple control titration of 10 µM FluoZin-3 in 20 
mM Tris buffer (pH 7.4) with Zn2+ reached the maximum fluorescence at stoichiometric amount 
of added Zn2+ (Figure 3.3.12 A). This indicated that the initial 10-12 µM Zn2+ was buffered by 
various high affinity adventitious binding sites for Zn2+ within the proteome (Reaction 18), that 
outcompeted FluoZin-3, a relatively high affinity Zn2+ sensor with Kd of 1.510
-8 M, for the 
added Zn2+.1, 2 However, as the added Zn2+ concentration was increased, fluorescence started 
increasing gradually (region II), suggesting the competition between relatively lower affinity 
proteomic adventitious sites and FluoZin-3 for the added Zn2+. Despite the enhancement at 
higher added Zn2+ concentration, the maximum fluorescence in this experiment never reached 
that of control titration, which might be due to the possible lower quantum yield of Zn-FluoZin-
3 complex in proteomic environment. The result of this experiment is particularly interesting, 
because it shows that the mobilized Zn2+ resulting from the reaction of nitric oxide and 
proteomic sulfhydryl groups in the presence of FluoZin-3 will be picked up by various high 
affinity adventitious proteomic binding sites instead of FluoZin-3, unless a very high 
concentration of Zn2+ is mobilized to saturate those adventitious sites before being sensed by 
FluoZin-3. The dissociation constant (Khigh) of these high affinity adventitious sites 
corresponding to region I was calculated to be in the order of 10-10 M. The calculation 
considered 15 µM Zn2+ as the end point of the titration of the high affinity binding sites. The 
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equilibrium constant (K) of the equation 10 was calculated, and then plugged into the equation, 
K = KZn-FluoZin3 / KProteomeZn, to find the dissociation constant of the high affinity sites, KProteomeZn. 
The dissociation constant of FluoZin-3, KZn-FluoZin3, was considered to be 1.5 x 10
-8 M. 
ProteomeZn + FluoZin3  Zn-FluoZin3 + Proteome   (10) 
K = ([Zn-FluoZin3]*[Proteome]) / ([ProteomeZn]*[FluoZin3])  (11) 
The dissociation constant (Kweak) of the proteome with weaker Zn
2+ binding affinity 
corresponding to region II was also calculated. The equilibrium concentrations of proteome and 
proteomeZn were represented by the following equations. 
[Proteome] = [CTotal proteome – (Cadded Zn
2+ - ((F-Fmin)/(Fmax – Fmin))CTotal FZ-3)] 
[ProteomeZn] = [Cadded Zn
2+ - ((F-Fmin)/(Fmax – Fmin))CTotal FZ-3], 
where C represents concentration, F fluorescence and FZ-3 FluoZin-3. Fmax and Fmin were taken 
as 7000 and 336 (corresponding to 15 µM added Zn2+) fluorescence units, respectively. By 
substituting [Proteome] and [ProteomeZn] in equation 11, the equilibrium constant (Kweak) 
becomes as follows. 
Kweak = b [(CTotal proteome / (Cadded Zn
2+ - a CTotal FZ-3)) – 1]   (12) 
where b = (F-Fmin) / (Fmax – F) and a = F-Fmin / Fmax - Fmin. The equation 12 containing two 
unknowns, Kweak and CTotal proteome, was solved for the added Zn
2+ concentrations of 60, 70, 80 
and 90 µM, and the average Kweak was found to be on the order of 10
-7 M. 
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The finding of the proteome’s high zinc buffering capacity indicates that observing Zn2+ 
mobilization using FluoZin-3 depends not only on the release of Zn2+ but also masking other 
adventitious sites that have high affinity for Zn2+. 
The ability of proteome to outcompete FluoZin-3 for Zn2+ was further studied in another way. 
10 µM Zn-FluoZin-3 complex was titrated by isolated proteome (13 µM Zn2+). As expected, 
initial fluorescence of Zn-FluoZin-3 decreased immediately by about 21% as 365 µg/mL of 
proteome (final concentration) containing 1.2 µM Zn2+ (final concentration) was added (Figure 
3.3.12 B). 
(Zn)-Proteome-SH + Zn2+ ⇋ (Zn)-Proteome.*Zn 
(Zn)-Proteome-S.*Zn + FluoZin-3 ⇋ (Zn)-Proteome-SH + *Zn-FluoZin-3 
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Figure 3.3.12 Stability of Zn-FluoZin3 in the presence of proteome. (A) Isolated proteome (12 
µM Zn2+) was incubated with 10 µM FluoZin-3 for 15 min. The reaction mixture was then 
titrated with increasing concentration of ZnCl2. (B) 10 µM Zn-FluoZin-3 complex in Tris (pH 7.4) 
was titrated with isolated proteome (13 µM Zn2+). 
I 
II 
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3.4 Zinc buffering of proteome and proteomic components responsible for it 
According to figure 3.3.11 A, in the titration of isolated proteome (12 µM Zn2+) with Zn2+ in the 
presence of 10 µM FluoZin-3, about 10 µM Zn2+ had to be added before any detectable Zn-
FluoZin3 was formed. This indicated that the initial 10 µM Zn2+ bound to the various proteomic 
zinc binding sites having higher for Zn2+ affinity than FluoZin-3. This flat region where no 
fluorescence was seen was referred to as ‘zinc buffering region I’. We wanted to investigate the 
proteomic sites that possess higher affinity for added Zn2+ than FluoZin3. Since many of the zinc 
binding sites in Zn-proteins utilize sulfhydryl groups as binding ligands, perhaps along with 
other groups, that coordinate Zn2+, we hypothesized that the added Zn2+ binds to proteomic 
sulfhydryl groups and create the zinc buffering phenomenon. To test this hypothesis, proteome 
was incubated with different thiol binding agents, such as N-ethylmaleimide (NEM), 
diethylamine NONOate (DEA-NO) and 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), followed by 
titration of the incubated proteome with Zn2+ in the presence of FluoZin-3 and Newport Green. 
 
Figure 3.4.1 Reaction of N-ethylmaleimide (NEM) with thiolate anion 
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Figure 3.4.2 Reaction of DTNB with sulfhydryl group of a thiol 
 
 
3.4.1 Titration of proteome incubated with N-ethylmaleimide (NEM) with Zn2+ in the presence 
of FluoZin-3 
Proteome containing 10 µM Zn2+ was incubated with 500 µM NEM for an hour. Following the 
incubation, 10 µM FluoZin-3 was added to the reaction mixture for 15 min. The reaction 
mixture was subsequently titrated with the increasing concentration of ZnCl2. The titration of 
proteome with ZnCl2 in the presence of 10 µM FluoZin-3 without NEM incubation was used as 
control experiment. As zinc was added to the NEM treated proteome, fluorescence started 
increasing immediately, as opposed to in control experiment where about 15 µM Zn2+ had to be 
added before any increase of fluorescence could be seen (Figure 3.4.3). Evidently, 500 µM NEM 
completely neutralized the initial zinc buffering capacity of proteome. The emission maximum 
of the fluorescence spectra at 520 nm suggested the formation of Zn-FluoZin3 complex. The 
loss of initial zinc buffering capacity of proteome following 500 µM NEM incubation can be 
explained as follows: NEM reacted with the proteomic sulfhydryl groups and as such blocked 
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the binding sites for the added zinc. Therefore, the added zinc was available to be complexed 
by FluoZin-3 and to form Zn-FluoZin3 with an enhancement of fluorescence. However, during 
the second phase of the reaction (after 15 µM ZnCl2 was added), the change of fluorescence 
was found to parallel that of the control suggesting that sulfhydryl groups were not the 
predominant functional groups that bind Zn2+ in this phase.  
Control: 
Phase 1: Proteome-SH + Zn2+  Proteome-S-Zn 
Phase 2: Proteome.Zn + FluoZin3  Proteome + Zn-FluoZin3 
NEM: 
Phase 1: Proteome-SH + NEM  Proteome-S-NEM 
Zn2+ + FluoZin3  Zn-FluoZin3 
Phase 2: Proteome.Zn + FluoZin3  Proteome + Zn-FluoZin3 
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Figure 3.4.3 Titration of proteome incubated with N-methyl maleimide (NEM) with ZnCl2 in 
the presence of FluoZin-3. (A) Fluorescence spectra of the titration of proteome (10 µM Zn2+) 
incubated with 500 µM NEM for an hour with ZnCl2 in the presence of 10 µM FluoZin-3. (B) 
Change of fluorescence at 520 nm with the increasing concentration of ZnCl2. The control 
experiment involves the titration of proteome without NEM incubation with ZnCl2 in the 
presence of 10 µM FluoZin-3. (C) The change of sulfhydryl concentration of proteome upon 
NEM incubation. 
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3.4.2 Titration of proteome incubated with N-ethylmaleimide (NEM) with ZnCl2 in the 
presence of Newport Green (NPG) 
As we have seen, the modification of proteomic sulfhydryl groups by NEM abolished the strong 
zinc binding affinity of proteome and thus FluoZin-3 could in part outcompete proteome for the 
added Zn2+, we repeated the experiment with a weaker zinc sensor Newport Green (NPG). 
Possessing low affinity for Zn2+ (KD  10
-6 µM), Newport Green cannot effectively compete with 
the proteome’s higher affinity binding sites for added Zn2+. According to the control experiment 
in Figure 3.4.4, when isolated proteome containing 5 µM Zn2+ was titrated with the increasing 
concentration of ZnCl2 in the presence of 10 µM Newport Green, about 25 µM Zn
2+ had to be 
added before NPG was able to bind Zn2+ with some enhancement of fluorescence. Newport 
green could not compete with proteome for the initial 25 µM Zn2+. During the second phase of 
the reaction, a competition also existed between the proteome’s moderate affinity zinc binding 
sites and Newport Green that resulted a gradual increase of fluorescence. However, when the 
proteome (5 µM Zn2+) was incubated with 500 µM NEM and then titrated with ZnCl2 in the 
presence of 10 µM NPG, proteome’s zinc buffering capacity was significantly reduced. 
Fluorescence enhancement due to the formation of Zn-NPG complex was observed after 10 µM 
ZnCl2 was added, as opposed to about 25 µM in the control experiment. Since a slight red shift 
in the emission maximum was observed, the possibility of the formation of ProteomeZn-NPG 
could not be ruled out. The noticeable loss of proteome’s zinc buffering capacity following 
incubation with NEM further implicated sulfhydryl groups in the proteomic competition with 
the sensor for Zn2+.  
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Figure 3.4.4 Titration of proteome incubated with N-methyl maleimide (NEM) with ZnCl2 in 
the presence of Newport Green (NPG). (A) Fluorescence spectra from the titration of proteome 
(5 µM Zn2+) incubated with 500 µM NEM with ZnCl2 in the presence of 10 µM Newport Green. 
(B) [Control]: Isolated proteome (5 µM Zn2+) was incubated with 10 µM NPG for 15 min, and 
then titrated with the increasing concentration of ZnCl2. [NEM]: Proteome (5 µM Zn
2+) was 
reacted with 10 µM NPG for 15 min followed by 500 µM NEM for another one hour. 
Subsequently, the final reaction mixture was titrated with ZnCl2. [NPG + Zn]: 10 µM NPG in 20 
mM Tris (pH 7.4) was titrated with ZnCl2. (C) The initial buffering region. 
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3.4.3. Titration of proteome incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB)  with 
ZnCl2 in the presence of FluoZin-3. 
The involvement of proteomic sulfhydryl groups in zinc buffering capacity of proteome was 
investigated using another thiol binding reagent 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB). 
Consistent with the results from the previous experiments with NEM, the strong zinc binding 
affinity was obliterated in the DTNB treated proteome. According to figure 3.4.5, fluorescence 
enhancement due to the formation of Zn-FluoZin3 complex was observed immediately after 
Zn2+ was added. Since DTNB reacted with proteomic sulfhydryl groups and blocked their 
reaction with the added Zn2+, FluoZin-3 was able to bind Zn2+ with an increment of 
fluorescence. By contrast, in the control experiment sigmoidal curve was seen for the increase 
of fluorescence with added Zn2+ indicating zinc buffering capacity of proteome. 
Proteome-SH + DTNB  Proteome-S-TNB + TNB 
Zn2+ + FluoZin-3  Zn-FluoZin3 
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Figure 3.4.5 Titration of proteome incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB)  
with ZnCl2 in the presence of FluoZin-3. (A) Fluorescence spectra of titration of proteome (6 µM 
Zn2+) incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) and 10 µM FluoZin-3 with the 
increasing concentration of ZnCl2 (0-100 µM). (B) Change of fluorescence intensity with the 
concentration of ZnCl2. 
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3.5 Status of Zn-proteome at different phases in a cell cycle 
Meeusen et al. reported that when LLC-PK1 cells were incubated with 30 µM TSQ for 30 min at 
37 0C, the fluorescence in cells due to the formation of TSQ-Zn-Proteome ternary adduct was 
asymmetric, i.e., some cells showed brighter fluorescence than others (Figure 3.5.1 A).65 
Moreover, when 30 µM Zn2+ and 3 µM pyrithione was added to the TSQ incubated cells, 
fluorescence enhancement was asymmetric as well (Figure 3.5.1 B). We hypothesized that this 
asymmetric distribution of fluorescence was attributed to the cells being at different phases of 
the cell cycle, where the cells synthesize varied quantities of zinc proteins and thus, different 
concentrations of TSQ-Zn-proteome would be generated when incubated with TSQ. To test this 
hypothesis, CCRF-CEM cells were incubated with different chemical blockers (Thymidine and 
Nocodazole) to block the cells at different phases of the cell cycle and then reacted with 
fluorescent sensors, such as TSQ and Zinquin. Thymidine blocks the cells at G1 phase, while 
Nocodazole at G2/M phase.99-104 The synchronization of the cells was confirmed by flow 
cytometry, which measures optical and fluorescence properties of single cells.105-107 Cell 
populations are sort out by the physical properties of the cells, such as size (represented by 
forward angle light scattering) and intracellular complexity (represented by side scattering). 
Cells are treated with fluorescent dyes which may bind or intercalate with cellular constituents 
such as DNA or RNA. Stained cells suspended in buffer are drawn into a stream generated by a 
surrounding sheath of isotonic fluid, which permit the cells to pass one at a time through an 
interrogation point. At this point, the cells are intersected with a beam of monochromatic light 
from a laser source. Based on the intensities of the emitted light, the cell populations are 
resolved.  We chose CCRF-CEM cells for this study because this is a suspension cell line, which 
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was found to be easier for cell sorting by flow cytometry than an adherent cell line, such as LLC-
PK1 used by Meeusen for his experiments. 
 
Figure 3.5.1 Fluorescence micrograph images of cellular Zn2+ observed after exposure to the 
Zn2+ fluorophore TSQ. (A) LLC-PK1 cells incubated with 30 µM TSQ in DPBS for 30 min at 37 0C. 
(B) Fluorescence increase of A after addition of 30 µM Zn2+ and 3 µM pyrithione for 1 min. (C) 
Fluorescence reduction of B following addition of 100 µM TPEN for 10 min.  
 
3.5.1 Cell viability assay  
Cell viability of CCRF-CEM cells treated with 2 mM thymidine or 100 ng/mL nocodazole for 24 
hours and control (untreated) cells was determined with Trypan Blue exclusion assay. 
Thymidine treated cells were found to be 90% viable, whereas nocodazole incubated cells 
showed about 80% viability. Control cells were almost 100% viable.  
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3.5.2 Reaction of TSQ and CCRF-CEM cells blocked at G1 phase by thymidine 
In order to block the cells at G1 phase, CCRF-CEM cells were treated with 2 mM thymidine for 
24 hours, and the synchronization of the cells at G1 phase was confirmed using Flow 
Cytometry. 13.05 x 106 thymidine-blocked cells were washed and resuspended in DPBS and 
then reacted with 20 µM TSQ, which resulted in gradual increase of fluorescence centered at 
470 nm indicating the formation of TSQ-Zn-Proteome (Figure 3.5.2 B). As a control experiment, 
10.5 x 106 untreated cells distributed throughout the cell cycle were reacted with 20 µM TSQ, 
which also showed fluorescence intensity with an emission maximum of 470 nm (Figure 3.5.2 
A). However, when the fluorescence intensity was normalized, the intensity per million cells for 
thymidine-blocked cells (187 units) were found to be 42% greater than that (132 units) of 
control cells. This greater fluorescence intensity for CCRF-CEM cells blocked at G1 phase 
suggests that cells at G1 phase synthesize greater concentration of zinc proteins than at other 
phases of a cell cycle and that the greater availability of zinc proteins allows TSQ to generate 
more TSQ-Zn-Proteome ternary adduct. After the reaction, both control and thymidine-blocked 
cells were sonicated, centrifuged and the cell lysates were analyzed for fluorescence. 
Consistent with the fluorescence intensities of the whole cells, the cell lysates also showed 
unequal normalized fluorescence (Figure 3.5.3). The cell lysate from the thymidine-blocked 
cells (170 fluorescence units per million cells) displayed 70% greater fluorescence intensities 
than that from the control cells (100 fluorescence units per million cells). Consequently, both 
the whole cells and the cell lysates support the hypothesis that cells at G1 phase synthesize a 
greater concentration of zinc proteins than at other stages of the cell cycle. 
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Figure 3.5.2 Reaction of TSQ and CCRF-CEM cells blocked at G1 phase by thymidine. (A) 
Control: 10.5 x 106 CCRF-CEM cells were harvested, resuspended in DPBS and then reacted with 
20 µM TSQ for 20 min. The fluorescence spectra was recorded every 5 min. (B) 13.05 x 106 
CCRF-CEM cells incubated with 2 mM thymidine for 24 hours were harvested, resuspended in 
DPBS and then reacted with 20 µM TSQ for 20 min. (C) Comparison of kinetics of both reaction. 
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Figure 3.5.3 Fluorescence spectrum of the cell lysate collected from CCRF-CEM cells (TSQ). Cells 
were incubated with 2 mM thymidine for 24 hours and then reacted with 20 µM TSQ for 20 
min. Cell lysates of both control and thymidine blocked cells were collected by the sonication of 
the cells followed by centrifugation. 
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3.5.3 Reaction of Zinquin (ZQ) and CCRF-CEM cells blocked at G1 phase by thymidine 
 CCRF-CEM cells synchronized at G1 phase by thymidine were also reacted with Zinquin (ZQ). 
18.55 x 106 cells blocked at G1 phase by 2 mM thymidine for 24 hours were washed and 
resuspended in DPBS, and subsequently reacted with 20 µM Zinquin (Figure 3.5.4 B). Like TSQ, 
Zinquin also formed ZQ-Zn-Proteome ternary adduct, as evident from the gradual enhancement 
of fluorescence intensity with a max of 470 nm. The reaction of 16.75 x 10
6 untreated cells with 
20 µM Zinquin was also performed as a control experiment. The control cells, like thymidine-
blocked cells, also showed fluorescence intensity centered at 470 nm (Figure 3.5.4 A). However, 
as the fluorescence intensities for both control and synchronized cells were normalized, the 
intensity from blocked cells (75 fluorescence units per million cells) was 47% greater than that 
from untreated cells (51 units per million cells). The cells lysates from both control and 
synchronized cells were collected following the reaction. As the fluorescence of the lysates was 
read, they also showed unequal normalized fluorescence intensities. The cell lysate from 
thymidine-blocked cells gave 139 fluorescence units per million cells, as opposed to 103 units 
for the cell lysate from control cells – 35% greater fluorescence intensity for the synchronized 
cells (Figure 3.5.5). The reaction of CCRF-CEM cells blocked at G1 phase with Zinquin once again 
supports the hypothesis that cells produce more zinc proteins during G1 phase of its life cycle 
than at other phases. 
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Figure 3.5.4 Reaction of Zinquin (ZQ) and CCRF-CEM cells blocked at G1 phase by thymidine. 
(A) Control: 16.75 x 106 CCRF-CEM cells were harvested, resuspended in DPBS and then reacted 
with 20 µM ZQ for 25 min. (B) 18.55 x 106 CCRF-CEM cells incubated with 2 mM thymidine for 
24 hours were harvested, resuspended in DPBS and then reacted with 20 µM ZQ for 25 min. (C) 
Comparison of kinetics of both reactions. 
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Figure 3.5.5 Fluorescence spectrum of the cell lysate collected from CCRF-CEM cells (ZQ). Cells 
were incubated with 2 mM thymidine for 24 hours and then reacted with 20 µM Zinquin ethyl 
ester (ZQee) for 20 min. Cell lysates of both control and thymidine blocked cells were collected 
by the sonication of the cells followed by centrifugation. 
 
 
 
 
 
 142 
 
3.5.4 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G1 phase by 
thymidine 
We have seen that the reaction of CCRF-CEM cells blocked at G1 phase by thymidine with TSQ 
or Zinquin, when compared with the untreated cells, suggests that cells synthesize greater 
concentration of Zn-proteins during G1 phase than any other phases of the cell cycle. To further 
verify this hypothesis, proteome was isolated from CCRF-CEM cells treated with 2 mM 
thymidine for 24 hours and then reacted with 20 µM TSQ. As the reaction progressed, 
fluorescence centered at 470 nm increased, indicative of the formation of TSQ-Zn-Proteome 
ternary adducts (Figure 3.5.6 B). The control experiment was done with the proteome isolated 
from the untreated CCRF-CEM cells. The reaction of control proteome with 20 µM TSQ also 
displayed fluorescence enhancement with max of 470 nm (Figure 3.5.6 A). Again, consistent 
with the whole cells results, the normalized fluorescence intensity resulting from the reaction 
of proteome and TSQ was significantly different for control cell proteome and thymidine-
blocked cell proteome. The fluorescence intensity per million cells synchronized in G1 phase 
was found to be double of that for control cells (Table 3.5.1). Moreover, the zinc content per 
million cells for thymidine-blocked cells was also 50% greater than that for untreated cells 
(Table 3.5.1). Therefore, the hypothesis that cells at G1 phase synthesize greater concentration 
of zinc proteins than at other phases of cell cycle is supported by experiments with both whole 
cells and isolated proteome. 
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Figure 3.5.6 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G1 phase 
by thymidine. (A) Control: 1.25 x 108 cells were harvested, sonicated and centrifuged. The cell 
lysate was then loaded onto a Sephadex G-75 column to collect the proteome. Following on, 
proteome was reacted with 20 µM TSQ for an hour.  (B) Proteome was isolated from 1.2 x 108 
CCRF-CEM cells treated with 2 mM thymidine for 24 hours. Isolated proteome was 
subsequently reacted with 20 µM TSQ for an hour. (C) Comparison of kinetics of both reactions. 
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Table 3.5.1: Comparison of the normalized fluorescence intensities from TSQ reaction and zinc 
contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine blocked 
cells 
   Ratio 
(Blocked/control) 
Fluorescence intensity per 
million cells (A.U.) 
Control 29 2 
Blocked 57 
Zinc content per million cells 
(nmol) 
Control 0.10  1.5 
Blocked 0.16  
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3.5.5 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at G1 
phase by thymidine 
The reaction of proteome isolated from CCRF-CEM cells that had been synchronized at G1 
phase was investigated with Zinquin (ZQ) as well. To do this, proteome was collected from 1.2 x 
108 CCRF-CEM cells treated with 2 mM thymidine for 24 hours, and subsequently reacted with 
20 µM Zinquin. Like TSQ, Zinquin also reacted with isolated proteome with an enhancement of 
fluorescence with an emission maximum of 470 nm (Figure 3.5.7 B). Control proteome isolated 
from 1.25 x 108 untreated CCRF-CEM cells was also reacted with 20 µM Zinquin. The control 
reaction also showed gradual increase of fluorescence with max of 470 nm (Figure 3.5.7 A). The 
results were comparable to those of the TSQ experiment. The normalized fluorescence intensity 
from the reaction of proteome isolated from CCRF-CEM cells blocked at G1 phase (41 
fluorescence units per million cells) was found to be almost double that for control (untreated) 
cells (22 units per million cells) (Table 3.5.2). The normalized zinc content was also found to be 
about 40% greater in case of synchronized cells – 0.15 nmol per million cells as opposed to 0.11 
nmol in control cells (Table 3.5.2). This experiment further strengthens the hypothesis that 
more proteome-bound Zn exists in cells at G1 phase than at any other phases of the cell cycle. 
Since ZQ and TSQ qualitatively bind to different Zn-proteins, these results imply that a broad 
range of Zn-proteins undergoes concentration changes during the course of the cell cycle. 
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Figure 3.5.7 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at 
G1 phase by thymidine. (A) Control: 1.25 x 108 cells were harvested, sonicated and centrifuged. 
The cell lysate was then loaded onto a Sephadex G-75 column to collect the proteome. 
Following on, proteome was reacted with 20 µM Zinquin for an hour.  (B) Proteome was 
isolated from 1.2 x 108 CCRF-CEM cells treated with 2 mM thymidine for 24 hours. Isolated 
proteome was subsequently reacted with 20 µM Zinquin for an hour. (C) Comparison of kinetics 
of both reactions. 
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Table 3.5.2: Comparison of the normalized fluorescence intensities from Zinquin reaction and 
zinc contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine 
blocked cells 
 
   Ratio 
(Blocked/Control) 
Fluorescence intensity per 
million cells (A.U.) 
Control 22 1.9 
Blocked 41 
Zinc content per million cells 
(nmol) 
Control 0.11 1.4 
Blocked 0.15 
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3.5.6 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G2/M phase by 
nocodazole  
The reactions of CCRF-CEM cells synchronized at G1 phase by thymidine or the isolated 
proteome from blocked cells with TSQ or Zinquin showed that cells synthesize more Zn-proteins 
in G1 phase than in other phases of the cell cycle. Next, we wanted to investigate the status of 
cellular zinc proteins at other phases of the cell cycle to extend the above findings. Logically, 
cells should produce fewer number of Zn-proteins at other phases than at G1 phase in order 
that the average for the divinding cell population be less than for G1. To probe this, another cell 
blocker nocodazole was chosen, which blocks the cells at G2/M phase. CCRF-CEM cells were 
treated with 100 ng/mL nocodazole for 24 hours to synchronize the cells at G2/M phase. Cell 
synchronization at G2/M phase was verified using Flow Cytometry. For this experiment, 
proteome was isolated from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL nocodazole for 
24 hours, and then reacted with 20 µM TSQ. As expected, fluorescence enhancement with an 
emission maximum of 470 nm was found (Figure 3.5.8 B). Proteome was isolated from 5.8 x 107 
untreated cells and reacted with 20 µM TSQ as a control experiment (Figure 3.5.8 A). When 
normalized, the fluorescence intensity for the blocked cells at G2/M phase (32 fluorescence 
units per million cells) was found to be about half of that for control cells (69 fluorescence units 
per million cells) (Table 3.5.3). The normalized zinc content in synchronized cells was also found 
to be 67% of the control – 0.08 nmol zinc per million cells as opposed to 0.12 nmol in control 
cells (Table 3.5.3). These results indicate that cells at G2/M phase synthesize less zinc 
containing proteins than at other phases of the cell cycle. 
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Figure 3.5.8 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G2/M 
phase by nocodazole. (A) Control: 5.8 x 107 cells were harvested, sonicated and centrifuged. 
The cell lysate was then loaded onto a Sephadex G-75 column to collect the proteome. 
Following on, proteome was reacted with 20 µM TSQ for 30 min.  (B) Proteome was isolated 
from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL nocodazole for 24 hours. Isolated 
proteome was subsequently reacted with 20 µM TSQ for 30 min. (C) Comparison of kinetics of 
both reactions. 
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Table 3.5.3: Comparison of the normalized fluorescence intensities from TSQ reaction and zinc 
contents of proteome isolated from control (untreated) CCRE-CEM cells and nocodazole 
blocked cells 
   Ratio 
(Blocked/control) 
 Fluorescence intensity per 
million cells (A.U.) 
Control 69 0.5 
Blocked 32 
Zinc content per million cells 
(nm) 
Control 0.12 0.67 
Blocked 0.08 
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3.5.7 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at G2/M 
phase by nocodazole 
The previous experiment - the reaction of TSQ and proteome collected from CCRF-CEM cells 
synchronized at G2/M phase by nocodazole - was compared with another that utilized ZQ in 
place of TSQ. In doing so, proteome was isolated from 5.8 x 107 CCRF-CEM cells treated with 
100 ng/mL nocodazole for 24 hours and then reacted with 20 µM Zinquin for 30 min. As 
expected, gradual increase of fluorescence centered at 470 nm was observed due to formation 
of ZQ-Zn-Proteome ternary complex (Figure 3.5.9 B). The result of this experiment was 
compared with a control experiment in which 20 µM Zinquin was reacted with proteome 
isolated from 5.5 x 107 untreated CCRF-CEM cells (Figure 3.5.9 A). Like TSQ, Zinquin reaction 
also showed that the normalized fluorescence intensity and zinc content are dissimilar for 
synchronized and control cells. The fluorescence intensity per million cells for blocked cells at 
G2/M phase (19 arbitrary units) was found to be 50% of that for control cells (40 arbitrary units) 
(Table 3.5.4). Consistently, zinc content per million cells for synchronized cells (0.08 nmol) was 
67% of that for control cells (0.12 nmol) (Table 3.5.4). This experiment again indicates that cells 
make relatively fewer number of zinc proteins during G2/M phase than at other phases of the 
cell cycle. 
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Figure 3.5.9 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at 
G2/M phase by nocodazole. (A) Control: 5.8 x 107 cells were harvested, sonicated and 
centrifuged. The cell lysate was then loaded onto a Sephadex G-75 column to collect the 
proteome. Following on, proteome was reacted with 20 µM Zinquin (ZQ) for 30 min.  (B) 
Proteome was isolated from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL for 24 hours. 
Isolated proteome was subsequently reacted with 20 µM Zinquin (ZQ) for an hour. (C) 
Comparison of kinetics of both reactions. 
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Table 3.5.4: Comparison of the normalized fluorescence intensities from Zinquin reaction and 
zinc contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine 
blocked cells 
   Ratio 
(Blocked/Control) 
 Fluorescence intensity per 
million cells (A.U.) 
Control 40 0.5 
Blocked 19 
Zinc content per million cells 
(nmol) 
Control 0.12 0.67 
Blocked 0.08 
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4. DISCUSSION 
Zinc is involved in a wide array of biological functions, including its structural and catalytic roles 
in various Zn-proteins.1, 2 Recent studies have revealed that Zn2+ also serves as a signaling 
molecule and a secondary messenger.41, 42 With the aim of studying the zinc trafficking across 
the cell membrane and within the cell, a number of fluorescent sensors with a wide range of 
stability constants have been designed and synthesized.1, 2 Conventionally, the appearance of a 
fluorescence microscopic signal following the incubation of cells with a cell permeable sensor, 
and its disappearance in the presence of the powerful membrane permeant chelator, TPEN, are 
interpreted as indicating the presence of labile, available Zn2+ in the cellular process under 
study.  However, in most cases, the chemical interaction between the fluorescent dye and 
various cellular components, and the sensor’s influence on the equilibria between the Zn-
proteins and the sensor itself have not been thoroughly studied. If the available free Zn2+ 
concentration is not comparable with the stability constant and the concentration of the sensor 
used, the conclusions drawn from the studies that employed the sensor may be ambiguous. 
Therefore, the biological chemistry of these fluorescent sensors needs to be properly 
understood.  
A number of studies have used the fluorescent sensor Newport Green (NPG) to image 
intracellular labile Zn2+.67-72 A sensor with a low Zn2+ binding affinity (Kd  10
-5-10-6 M), NPGA, its 
acid form, binds Zn2+ in vitro with a 1:1 stoichiometry and displays a two-fold enhancement of 
fluorescence upon binding Zn2+, which is readily reversed by TPEN. However, some limitations 
of NPG include its high background fluorescence and the unaltered emission maximum of 530 
nm following Zn2+ binding. Moreover, both NPGA and Zn-NPGA show non-linear growth of 
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fluorescence at increasing concentrations, possibly, due to the -stacking of fluorescein 
reporters of the sensor. This property complicates its use in quantitative measurements. In 
addition, because of its small binding constant for Zn2+, it may encounter cellular ligands, 
including proteins and small molecules such as glutathione, that compete with NPG for 
intracellular labile Zn2+. This study examined the effectiveness of NPG as a zinc sensor within 
the cellular environment. 
When LLC-PK1 cells were reacted with the cell permeable, non-fluorescent ester form NPGE, a 
slow increase of fluorescence was observed, which continued growing despite the addition of 
TPEN. This suggested that the fluorescence enhancement originated from the slow hydrolysis of 
the non-fluorescent ester NPGE to the fluorescent acid NPGA catalyzed by cellular esterases. 
NPGA did not react with the native distribution of Zn
2+ to produce any measurable Zn-NPG or 
NPG-Zn-Proteome ternary adduct, unlike TSQ and Zinquin (ZQ).50, 65 Strangely, much of the 
NPGA generated following hydrolysis of NPGE was found in the extracellular medium, indicating 
the efflux of NPGE or NPGA by some unknown mechanism. This finding indicated that the 
fluorescence enhancement attributed to the imaging of intracellular Zn2+ reported in some 
studies might involve the extracellular Zn2+. 
Filtration the cell lysate collected from LLC-PK1 cells incubated with NPGE showed that NPGA 
made non-specific interactions with proteome, as majority of fluorescence was associated with 
the high molecular weight retentate and was unaffected when TPEN was added. Similar results 
obtained from the reaction of isolated proteome with NPGE or NPGA further supported the non-
specific interaction of NPGA with proteome. When reacted with individual Zn-proteins instead 
of the whole proteome, such as alcohol dehydrogenase (Zn-ADH) and carbonic anhydrase (Zn-
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CA), NPGE slowly converted to NPGE, accompanied by a slow increase of fluorescence, meaning 
that both Zn-proteins acted as esterases which catalyzed the conversion. TPEN could not 
reverse the course of fluorescence increase, which suggested that no NPG-Zn-ADH or NPG-Zn-
CA ternary adduct formed. However, filtration of the final reaction mixtures demonstrated that 
NPGA interacted non-specifically with both Zn-ADH and Zn-CA, consistent with the proteome 
results. By contrast, both TSQ and Zinquin (ZQ) form ternary adducts TSQ/ZQ-Zn-(CA/ADH) with 
both Zn-proteins.50, 65  Both NPGA and Zn-NPGA showed significant interaction with bovine 
serum albumin, which has a well-defined zinc binding site, as well. As NPGA or Zn-NPGA was 
reacted with BSA, a noticeable enhancement of fluorescence was observed and the emission 
maximum shifted from 532 nm to 538 nm. Following filtration of the final reaction mixtures, all 
of the fluorescence intensity was found associated with BSA, which further confirmed the 
interaction of BSA and NPGA or Zn-NPGA. This random binding of NPGA to proteome, further 
supported by the reactions with individual proteins, including alcohol dehydrogenase, carbonic 
anhydrase and bovine serum albumin, is an undesired property of a cellular metal binding 
sensor. A recent paper also reported the interaction of NPG with proteomic fractions following 
gel filtration.108 
From the reactions of NPG with the whole cells, isolated proteome and individual proteins, it 
was concluded that NPG is not reactive with the static distribution of cellular zinc. Next, 
proteome, including Zn-proteome, together with NPGA was titrated with Zn
2+ to model the 
cellular dynamic Zn2+ pool to examine if NPGA with its low zinc binding constant can bind to the 
mobile Zn2+ within the proteomic environment. No Zn-NPGA formed even after the addition of 
about five times Zn2+ concentration of the native proteome, meaning that proteome contains a 
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large number of Zn2+ binding sites with zinc binding affinity much higher than NPG, which 
effectively outcompete NPG for the added Zn2+ (reaction 1). This property of proteome is 
referred to as its zinc buffering capacity. 
Proteome + NPGA + Zn
2+ ⇌ Proteome•Zn + NPGA          (1) 
Beyond this buffering region, NPGA could weakly compete with the proteome, indicating that 
proteome has additional binding sites with zinc binding stability constants comparable to NPGA 
(reaction 2). 
Proteome•Zn + NPGA ⇌ Proteome + Zn-NPGA            (2) 
Proteome could also chelate Zn2+ from pre-incubated Zn-NPGA complex to form Proteome•Zn, 
further substantiating its additional zinc binding sites with greater stability constants than NPG. 
Together, these titration experiments implied that Zn-NPGA complex is not stable enough to 
survive within the proteomic environment, where a large number of proteomic ligands can 
outcompete NPGA for Zn
2+. This finding is very significant, because it brings forth the question 
of how NPGA acts an intracellular sensor to image mobile Zn
2+ reported in many studies by 
surpassing the high zinc buffering capacity of proteome. Possibly, the proteome’s zinc buffering 
capacity is cellular compartment specific, i.e. the proteins with high zinc buffering capacity are 
limited to certain cellular organelles such that NPGA can bind free or labile pool of Zn
2+ in some 
parts of the cell. However, when subcellular proteome, including cytosolic, mitochondrial and 
nuclear proteome, were collected and subsequently, titrated with Zn2+, buffering capacity was 
observed in all of them, regardless of the compartment. Besides proteome, glutathione, 
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another potential Zn2+ binding small molecule ligand that exists in mM concentration in 
eukaryotic cells and has an apparent stability constant for Zn2+ at pH 7 of 104.2, also competed 
with NPGA for Zn
2+.81 In addition, Zn-NPGA showed weak stability in the presence of micromolar 
concentration of glutathione, suggesting that there are plethora of potential ligands, both 
proteome and small molecules, including glutathione, which compete with NPGA to bind labile 
Zn2+. So under this circumstance, NPGA’s efficacy as an intracellular zinc sensor is questionable.  
The finding that Zn-NPGA complex is inadequately stable observed from in vitro experiments 
(proteome and glutathione) was in agreement with in vivo observations. When LLC-PK1 cells 
pre-incubated with NPGE were treated with Zn(pyrithione)2, Zn
2+ complexed with the ionophore 
pyrithione, an immediate increase fluorescence was observed. However, the cell impermeable 
strong Zn2+ chelator, EDTA, almost completely quenched the increased fluorescence, revealing 
that the signal enhancement originated from extracellular Zn-NPGA formation. The extracellular 
NPGA may have resulted from the efflux of NPGA following the conversion from NPGE described 
earlier. Although pyrithione shuttled into cells a significant amount of Zn2+ - almost equal to 
50% of the total proteomic Zn2+ concentration – the intracellular NPGA could not compete with 
the cellular competitors to generate any Zn-NPGA, because no measurable intracellular 
fluorescence enhancement could be detected. This experiment once again encourages the 
possibility that the fluorescence enhancement which was attributed to intracellular Zn-NPGA 
formation reported in various studies may partly originate from the extracellular Zn-NPGA. 
To further substantiate the observation that NPGA cannot effectively compete with the 
competitive proteomic and small molecule ligands for the mobile Zn2+, isolated proteome pre-
treated with NPGA was reacted with two thiol binding reagents, a nitric oxide donor 
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diethylamine NONOate (DEA-NO) and N-ethylmaleimide (NEM), which react with proteomic 
sulfhydryl groups and liberate Zn2+ coordinated by thiolate ligands in native Zn-proteins. 
Following the reaction with DEA-NO, no detectable Zn-NPGA was formed, implying that the 
liberated Zn2+ from native Zn2+ binding sites was captured by competitive proteomic and/or 
small molecule ligands. Interestingly, NPGA reacted independently with nitric oxide (NO) 
accompanied by fluorescence enhancement and unaltered emission maximum, meaning that 
NPGA acts also as a nitric oxide (NO) sensor. Therefore, previous studies that employed NPGA to 
detect Zn2+ liberated upon reaction with nitric oxide might have to be re-examined, since the 
fluorescence increase perhaps stemmed from NPGA’s binding to nitric oxide (NO), not from Zn-
NPGA.  
The other thiol binding reagent NEM reacted with about 50% of the proteomic sulfhydryl 
groups and resulted in a small increase of fluorescence. However, TPEN could only partially 
reverse the fluorescence enhancement, indicating that an insignificant amount of Zn-NPGA had 
formed. By contrast, Zinquin, a higher affinity zinc sensor than NPG, binds Zn2+ mobilized from 
proteome following the reaction with NEM as Zn(ZQ)2.
83 Apparently, proteomic ligands bind the 
newly liberated Zn2+ with higher affinity than NPGA, further questioning NPGA’s ability to image 
free Zn2+ in the cellular environment.  
Although a number of studies used NPG to image intracellular free Zn2+, this present work 
questions the stability of Zn-NPGA in all cellular compartments. Newport Green, because of its 
small stability constant for Zn2+, has to compete with a host of adventitious proteomic sites 
with higher affinity for Zn2+. Therefore, these results bring into the question what pools of 
intracellular or extracellular Zn2+ are imaged by Newport Green. 
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Having found that Newport green with a modest stability constant for Zn2+ cannot serve as a 
good sensor for imaging Zn2+ within the cellular environment, next we studied the biological 
chemistry of another fluorescent Zn2+ sensor Zinpyr-1 (ZP1) that has a stability constant higher 
than Newport Green.  The ZP1 structure possesses two di-(2-picolyl)amine chelators that bind 
Zn2+ ions (Figure 1.2). It binds the first Zn2+ with much higher affinity (Kd 0.7 nM) but with very 
weak fluorescence, while the weaker binding of the second Zn2+ (Kd 85 µM) is associated with 
much higher increase of fluorescence.1  Moreover, the half-saturated complex ZP1-Zn displays 
an emission maximum of 535 nm, but shifts to 525 nm as the fully saturated complex ZP1(Zn)2 
is generated. Since the strong binding of first Zn2+ results in very weak fluorescence and the 
weak binding of second Zn2+ gives larger fluorescence increase, the gradual binding of Zn2+ to 
ZP1 produces a sigmoidal shaped titration curve. This property – production of weak 
fluorescence upon strong binding of the first Zn2+ - makes its use as a cellular sensor 
complicated. 
The incubation of LLC-PK1 cells with ZP1 resulted in very weak fluorescence with an emission 
maximum of 535 nm. Neither TPEN, a cell permeable strong Zn2+ chelator, nor EDTA, a cell 
impermeable strong Zn2+ chelator, could quench the fluorescence. This apparently indicated no 
reaction between ZP1 and intracellular, native Zn2+ or extracellular Zn2+. However, since the 
strong binding of Zn2+ to ZP1 gives very weak fluorescence, it is difficult to conclude definitively 
that no reaction occurred between ZP1 and cellular Zn2+. When the cell lysate obtained 
following the incubation of LLC-PK1 cells with ZP1 was separated using size exclusion 
chromatography, a significant pool of high molecular weight fluorescence was observed that 
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co-existed with most of the Zn2+ concentration in the cell lysate. This suggested the formation 
of ternary adduct, ZP1-Zn-Proteome, between ZP1 and native Zn-Proteome. 
To further investigate the possibility of the formation of ZP1-Zn-Proteome ternary adduct, ZP1 
was reacted with isolated Zn-Proteome. The fluorescence with 540 nm emission maximum 
generated from the reaction was reduced by 44% by TPEN.  Moreover, upon gel filtration of the 
final reaction mixture of ZP1 and isolated Zn-proteome, the majority of the fluorescence was 
found in the high molecular weight, proteome region. TPEN quenched the integrated 
fluorescence intensity of the proteome fractions by about 25%. Together, these experiments 
again pointed to the production of ZP1-Zn-Proteome ternary adduct. 
As another evidence of its reaction with Zn-proteome, ZP1 displaced TSQ from TSQ-Zn-
Proteome ternary adduct generated by the reaction of TSQ and Zn-Proteome and formed new 
ternary adduct species ZP-Zn-Proteome. This was quite evident from the disappearance of 
fluorescence intensity of TSQ-Zn-Proteome at 470 nm, and the emergence of 540 nm 
fluorescence due to the formation of ZP1-Zn-Proteome. TPEN caused significant reduction of 
the integrated fluorescence of proteome at 540 nm. 
Besides its reaction with native Zn-proteome, ZP1 forms a ternary adduct, Proteome•Zn-ZP1, 
with isolated proteome and added Zn2+ as well.  As isolated proteome was titrated with Zn2+ in 
the presence of ZP1, a progressive increase of fluorescence was observed immediately, which 
resulted in a hyperbolic graph of fluorescence increase vs. added Zn2+, unlike the titration of 
ZP1 with Zn2+ that gives a sigmoidal shaped fluorescence vs. Zn2+ binding curve due to the 
unequal binding affinities of two Zn2+ ions for ZP1 and their distinct fluorescence properties.  
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Moreover, throughout the titration the emission maximum remained unaltered at 535-540 nm. 
Gel filtration of the final reaction mixture showed that almost all of the fluorescence intensity 
and Zn2+ were found in the high molecular weight fractions. In addition, TPEN reversed the 
integrated fluorescence intensity of the proteome fractions almost by 50%. These results imply 
that ZP1 reacts with Zn2+ that adventitiously binds proteome, and forms Proteome•Zn-ZP1 
ternary adduct.    
The generation of ternary adduct, Proteome•Zn-ZP1, was further supported from the reaction 
between isolated proteome and ZP1(Zn)2. The reaction caused a red-shift of the emission 
maximum to 540 nm from ZP(Zn)2’s 525 nm peak. Furthermore, following gel filtration of the 
final reaction mixture, most of the fluorescence and almost all of the zinc were located in the 
high molecular weight fractions. TPEN reduced the integrated fluorescence intensity of the high 
molecular weight fractions by almost 82%. 
The titration of ZP1 with alcohol dehydrogenase (Zn-ADH), used as a model Zn-protein, 
displayed a gradual enhancement of fluorescence at 536 nm, which was reversed almost 
completely by TPEN. This suggested the generation of ternary adduct ZP1-Zn-ADH between ZP1 
and alcohol dehydrogenase followed by the possible displacement of ZP1 by TPEN to form 
TPEN-Zn-ADH. The TPEN reaction is consistent with the previous studies which demonstrated 
that it binds Zn-ADH in the form of TPEN-Zn-ADH.67 However, the continuing increase of 
fluorescence even at the concentration of alcohol dehydrogenase that contained Zn2+ six times 
higher than the concentration of ZP1 indicated that the interaction between ZP1 and Zn-ADH to 
form ZP1-Zn-ADH is weak. The location of the majority of the fluorescence in the low molecular 
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weight fractions – which resulted from ZP1’s intrinsic fluorescence - following the gel filtration 
of the final reaction mixture of the reaction between ZP1 and alcohol dehydrogenase further 
supported the weak interaction ZP1 and Zn-ADH that was disrupted during the gel filtration.  
Taken together, the reactions of ZP1 with LLC-PK1 cells, isolated proteome and model proteins, 
such as alcohol dehydrogenase in the absence or presence of externally added Zn2+ suggested 
that ZP1 reacts with Zn-Proteome and results in the formation of ternary adduct ZP1-Zn-
Proteome with native Zn-Proteome or Proteome•Zn-ZP1 with externally added Zn2+ and 
proteome. Therefore, the use of ZP1 to image cellular free or labile Zn2+ is complicated as it also 
images Zn-protein. Thus, careful investigations are required in the studies that employ ZP1 to 
image free or labile Zn2+. 
The titrations of isolated proteome with externally added Zn2+ in the presence of Newport 
Green or Zinpyr-1 were carried out as model reactions to mimic the release of Zn2+ from various 
intracellular Zn2+ stores such as endoplasmic reticulum, vesicles etc. which have been imaged 
by different fluorescent sensors in various studies. However, we have seen that in those model 
reactions, NPGA cannot compete with proteome for the added Zn
2+ until very high 
concentrations of Zn2+ were added. And ZP1 formed ternary adduct, Proteome•Zn-ZP1, with 
Zn2+ that is adventitiously bound to proteome.  In neither case did the sensor image free Zn2+ as 
various studies claimed.  Therefore, the studies which used a fluorescent Zn2+ sensor to sense 
Zn2+ released from intracellular stores or liberated from Zn-proteome followed by the 
introduction of a physiological or pathological agent that induced the liberation of Zn2+ need 
further study.  
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To put the results of those model Zn2+ release experiments into cellular context, we studied the 
reaction of nitric oxide (NO) with cellular or isolated Zn-proteome. A number of studies 
reported the imaging of free Zn2+ liberated following the incubation of cells with NO by 
fluorescent sensors.54, 56, 109, 110 In one early study, sheep pulmonary alveolar endothelial cells 
(SPAEC) exposed to the NO donor, S-NO-cysteine, and ZQ displayed a 25% increase in 
fluorescence compared with controls, which led to the conclusion that Zn2+ mobilized by NO 
plays a key role in NO-dependent vessel constriction.56  The present work examines the 
reaction of LLC-PK1 cells or isolated proteome with another NO donor, diethylamine NONOate 
(DEA-NO), with fluorescent sensors having varied binding affinities for Zn2+. 
The reaction of LLC-PK1 cells with Zinquin (ZQ) reacted with 15-20% of Zn-proteome as 
expected and generated the ternary adduct species ZQ-Zn-Proteome – evident from the 
appearance of 470 nm emission maximum. Upon the subsequent introduction of DEA-NO, 
fluorescence further increased at 470 nm, indicating the formation of additional ternary adduct 
species. In addition, along with 470 nm, 490 nm emission, characteristic of Zn(ZQ)2  complex 
formation, appeared. The gel filtration of the cell lysate once again supported the generation of 
both ternary adduct species and the Zn(ZQ)2 complex. Together, these results suggested that 
Zn2+ mobilized from Zn-proteome upon NO exposure binds adventitiously to various proteomic 
sites possessing zinc binding affinity. The excess ZQ then makes additional ternary adduct 
species Proteome•Zn-ZQ, which accounts for the fluorescence increase at 470 nm. Due to its 
high stability constant of Zn2+ binding, ZQ can also generate some Zn(ZQ)2 complex through 
ligand substitution. These results can be described by the following equations: 
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Zn-S-Proteome + NO ⇌ NO-S-Proteome + Zn2+  
Proteome + Zn2+ ⇌Proteome•Zn 
Proteome•Zn + ZQ ⇌ Proteome•Zn-ZQ (470 nm) 
Proteome•Zn + 2ZQ ⇌ Proteome + Zn(ZQ)2 (490 nm) 
The results were verified with the reaction of isolated proteome with ZQ followed by DEA-NO. 
When the reaction was repeated with another zinc sensor TSQ, closely related to ZQ structure, 
along with TSQ-Zn-Proteome ternary adduct generated from the reaction of TSQ and 15-20% of 
the native Zn-proteome, additional ternary adduct species Proteome•Zn-TSQ formed through 
similar mechanism as of ZQ. However, because it is a weaker sensor than ZQ, TSQ could not 
form any Zn(TSQ)2 complex by chelating Zn
2+ from Proteome•Zn. This explanation is consistent 
with our previous result of the reaction of proteome with DEA-NO in the presence of Newport 
Green. Since Newport Green is a weak zinc sensor, it could not compete with proteome for the 
liberated Zn2+, and thus was unable to form any measurable Zn-NPG. However, in both cases, 
proteomic sulfhydryl concentration were significantly reduced, confirming the reaction of NO 
and proteomic sulfhydryl groups, which resulted the liberation of proteomic Zn2+. 
To further validate the results of ZQ and TSQ experiments, isolated proteome pre-treated with 
ZQ or TSQ was titrated with Zn2+, a model used to mimic liberation of Zn2+ following NO 
exposure. As anticipated in both cases, additional ternary adduct Proteome•Zn-ZQ/TSQ was 
generated from the reaction of ZQ/TSQ and Zn2+ adventitiously bound to proteome, 
Proteome•Zn. However, unlike NO experiment with ZQ, no Zn(ZQ)2 complex was produced. This 
implied that proteome’s adventitious zinc binding sites perhaps involve sulfhydryl groups. Since 
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a significant number of these sulfhydryl groups are modified by NO in the DEA-NO experiment, 
some of the mobilized Zn2+ may be unable to bind these sites and become accessible to ZQ to 
produce the Zn(ZQ)2 complex. By contrast, in this titration experiment, due to the absence of 
added sulfhydryl binding agent, most of the proteomic sulfhydryl groups are unmodified and 
thus prevent ZQ from binding any added Zn2+ to form Zn(ZQ)2 complex.  
Having found that ZQ and TSQ, due to their difference in zinc binding affinity, reacted 
differently with proteome exposed to DEA-NO, we turned to a third sensor FluoZin-3, another 
zinc sensor with intermediate binding affinity (15 nM) between TSQ and ZQ.1 Unlike ZQ and 
TSQ, FluoZin-3 does not react with native Zn-proteome. Following exposure of proteome 
incubated with FluoZin-3 to DEA-NO, a gradual increase of fluorescence insensitive to TPEN was 
observed, suggesting that the fluorescence increase due to the modification of the fluorophore, 
not because of the binding of Zn2+. Evidently, FluoZin-3, like Newport Green, reacts 
independently with nitric oxide (NO) accompanied by fluorescence enhancement. In this case, 
neither Proteome•Zn-FluoZin3 ternary adduct nor Zn-FluoZin3 could be detected. This 
suggested that FluoZin-3 cannot effectively competed for Zn2+ with modified or adventitious 
proteomic binding sites. 
Thus, three different results were obtained from the reaction of proteome with the nitric oxide 
donor, DEA-NO, depending on the zinc binding affinity of the fluorescent sensor used. This 
clearly demonstrates that the Zn2+ binding properties of proteome under different cellular 
conditions, e.g. proteomic sulfhydryl groups modified by NO in this case play an important role 
to determine how the zinc sensor will function. For example, among the three sensors used in 
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this study, ZQ could effectively compete with proteome for the mobilized Zn2+, only when the 
proteomic zinc binding sites were modified by NO. Therefore, the imaging of Zn2+ labilized by 
the exposure of NO depends on the zinc binding characteristics of the proteome and the 
relative zinc binding affinity of the sensor compared with that of proteome’s adventitious sites.  
That proteome has numerous high affinity Zn2+ binding sites as revealed in the above titration 
experiment suggests that Zn2+ may be transported to native Zn-proteins via ligand substitution 
involving these non-specific high affinity sites. 
Apart from doubting the effectiveness of a large number of zinc sensors to image labile Zn2+ 
within the proteomic environment, the apparent strong affinity of mobilizable Zn2+ for the 
above mentioned non-specific proteomic binding sites raises other important questions.  For 
example, if the proteome provides a strong buffer for Zn2+, how does intracellular Zn2+ signaling 
take place?   
From a number of experiments, including the titration of proteome with Zn2+ in the presence of 
Newport Green, ZP1, TSQ, Zinquin and FluoZin-3, it is convincingly evident that beside the 
strong Zn2+ binding sites in native Zn-proteins, proteome has a large number of high affinity 
adventitious zinc binding sites. However, as was seen in the reaction of proteome incubated 
with ZQ and DEA-NO, nitric oxide (NO) significantly modified the proteomic sulfhydryl groups, 
which coincided with the proteome’s reduction of zinc buffering capacity and as such ZQ could 
effectively compete with proteome to generate Zn(ZQ)2 complex. This observation led us to the 
hypothesis that proteomic sulfhydryl groups are primarily involved in these adventitious high 
affinity Zn2+ binding sites. To examine this idea further, proteomic sulfhydryl groups were 
modified by thiol binding reagents, such as N-ethylmaleimide (NEM) and 5,5-dithio-bis-(2-
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nitrobenzoic acid) (DTNB), before treatment with Zn2+. Interestingly, when the proteome was 
incubated with NEM or DTNB, its high affinity Zn2+ binding sites were significantly reduced, as 
monitored by both FluoZin-3 and Newport Green. This finding clearly implicated proteomic 
sulfhydryl (-SH) groups as the high affinity zinc binding sites that outcompeted FluoZin-3 for the 
added Zn2+. This discovery takes us one step further into understanding the mechanism of 
cellular zinc trafficking. Moreover, this finding once again draws attention to the fact that the 
ability of the sensor to image free or labile Zn2+ is contingent on the proteome’s Zn2+ binding 
characteristics. For example, reaction of nitric oxide (NO) with the proteomic sulfhydryl (SH) 
groups reduces their availability to bind Zn2+ in the presence of ZQ and other sensors, and this 
proteomic condition allows the sensors to bind Zn2+ accompanied by a fluorescence 
enhancement. Various studies reported that the release of Zn2+, induced by the exposure of 
nitric oxide donors, precedes a Zn-dependent regulatory/signaling  process, often inferred from 
the fluorescence increase of the zinc sensor used. However, the sensor’s ability to bind Zn2+ 
might be dependent on the diminished zinc buffering capacity of proteome resulting from the 
modification of the sulfhydryl groups by NO.  We know this because in unperturbed condition 
of the proteome, most of the fluorescent zinc sensors, including high affinity sensors Zinquin 
and FluoZin-3, are unable to bind mobile Zn2+. The pioneering discovery by Meeusen et al. that 
inspired this investigation of the chemical biology of fluorescent zinc sensors, such as Newport 
Green and Zinpyr-1, was that TSQ images Zn-proteins, not free Zn2+, through the formation of 
ternary adduct TSQ-Zn-Protein – evident from its signature emission maximum of 470 nm, 
unlike the Zn(TSQ)2 complex that displays 490 nm emission maximum. The incubation of LLC-
PK1 cells with TSQ followed by Zn(Pyrithione)2 resulted in bright fluorescence, as observed 
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under fluorescence microscope, due to the formation of TSQ-Zn-Proteome ternary adduct and 
TPEN, a strong Zn2+ chelator, reversed the fluorescence to a significant measure. However, the 
bright fluorescence following the introduction of TSQ and Zn(Pyrithione)2 was not 
symmetrically distributed among the cells – some showed much more intense fluorescence 
than others. Seeking the reason for this asymmetric fluorescence among the cells led us to the 
hypothesis that cells at different stages of the cell cycle make unequal concentrations of 
particular Zn-proteins.  In turn, this may account for the unequal brightness of fluorescence in 
different cells within a normal population of dividing cells.  
CCRF cells were synchronized at G1 phase by the treatment with thymidine and subsequently 
reacted with TSQ/Zinquin.  Cells showed twice as much fluorescence and zinc content per cell 
as the untreated population. The proteome isolated from thymidine treated CCRF cells 
displayed similar results. By contrast, proteome isolated from cells synchronized at G2/M phase 
by the incubation with nocodazole and its subsequent reaction with TSQ/ZQ resulted in about 
half of the fluorescence intensity and two-third of the zinc content as the untreated cells. 
Together, these findings supported the hypothesis that cells synthesize different amounts of 
zinc proteins at different stages of its cell cycle.  The results explain the non-uniform brightness 
of fluorescence among the neighboring cells following the treatment with TSQ and 
Zn(Pyrithione)2 observed by Meeusen et al.
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5. SUMMARY  
Taken altogether, this study has yielded some important discoveries, which are significant to 
the understanding of the biological chemistry of the fluorescent zinc sensors, particularly 
Newport Green and Zinpyr-1, and also, of cellular zinc trafficking. We have shown that due to 
its modest Zn2+ binding affinity and as such its inability to outcompete proteome for Zn2+, 
Newport Green, by itself, cannot act as an effective sensor to image labile Zn2+ within the 
proteomic environment. Moreover, some of its unwanted properties, such as the slow 
hydrolysis of its weakly fluorescent ester form into the strongly fluorescent acid form, and its 
efflux into the extracellular medium, further complicate its use as a cellular Zn2+ sensor. The 
study of Zinpyr-1 has exposed its ability to generate ZP1-Zn-Proteome ternary adduct – both 
with native Zn-Proteome and with proteome and the added Zn2+.  In addition, the weaker 
fluorescence signal resulting from the first Zn2+ binding with higher affinity makes its use as a 
cellular sensor even more convoluted.  
The reaction of the proteome with diethylamine NONOate (DEA-NO) monitored by three 
different sensors – Zinquin, TSQ and FluoZin-3 – revealed that the formation of Zn-Sensor 
complex following the liberation of Zn2+ from Zn-proteome is dependent on the relative binding 
affinity of the sensor used. The reaction with Zinquin (ZQ), a high affinity sensor, yielded a 
significant quantity of Zn(ZQ)2, whereas no measurable Zn(TSQ)2 or Zn-FluoZin3 was formed 
from the reactions of DEA-NO modified Zn-proteome with TSQ or FluoZin-3, relatively lower 
affinity sensors than Zinquin.  
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The titration experiment of proteome incubated with FluoZin-3 with Zn2+ resulted in the 
important finding that proteome possesses a large concentration of high affinity Zn2+ binding 
sites having Kd for Zn
2+ on the order of 10-10 M.  These high affinity Zn2+ binding sites may serve 
as intermediate carriers of Zn2+, following entry into the cell, to convey Zn2+ to apo-proteins to 
form native Zn-proteins - a pathway still not well understood. Following on, we have discovered 
that these high affinity Zn2+ binding sites of proteome use sulfhydryl groups to bind Zn2+, 
evident from the abolition of these sites when proteome was reacted with sulfhydryl binding 
reagents, such as N-ethylmaleimide (NEM) and 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB). This 
finding will drive us further into the understanding of the intermediate pathway of Zn-protein 
formation. Last but not least, the cell cycle study has resulted in another important revelation 
that cells synthesize varied amount of zinc proteins at different stages of the cell cycle. All these 
findings will, surely, enhance the overall understanding of the cellular zinc trafficking between 
and within the cellular compartments. 
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